BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994;19:1321-1324. [PMID: 8175159 DOI: 10.1002/hep.1840190538] [Cited by in Crossref: 608] [Cited by in F6Publishing: 462] [Article Influence: 21.7] [Reference Citation Analysis]
Number Citing Articles
1 Pasquier C, Njouom R, Ayouba A, Dubois M, Sartre MT, Vessière A, Timba I, Thonnon J, Izopet J, Nerrienet E. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 2005;77:390-8. [DOI: 10.1002/jmv.20468] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
2 Kaysheva AL, Ivanov YD, Zgoda VG, Frantsuzov PA, Pleshakova TO, Krokhin NV, Ziborov VS, Archakov AI. Visualization and identification of hepatitis C viral particles by atomic force microscopy combined with MS/MS analysis. Biochem Moscow Suppl Ser B 2010;4:15-24. [DOI: 10.1134/s1990750810010038] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
3 Al-Ahdal MN, Rezeig MA, Kessie G. Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from PCR-amplified core region of the virus genome. Ann Saudi Med 1997;17:601-4. [PMID: 17338004 DOI: 10.5144/0256-4947.1997.601] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
4 Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JY. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology. 1998;28:225-230. [PMID: 9657116 DOI: 10.1002/hep.510280129] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 4.1] [Reference Citation Analysis]
5 Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Hamba H, Shuto T, Yamamoto T, Ikebe T, Kinoshita H. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 1999;86:793-8. [DOI: 10.1002/(sici)1097-0142(19990901)86:5<793::aid-cncr14>3.0.co;2-k] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
6 Hirano M, Kaneko S, Yamashita T, Luo H, Qin W, Shirota Y, Nomura T, Kobayashi K, Murakami S. Direct Interaction between Nucleolin and Hepatitis C Virus NS5B. Journal of Biological Chemistry 2003;278:5109-15. [DOI: 10.1074/jbc.m207629200] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
7 McHutchison JG, Giannelli G, Nyberg L, Blatt LM, Waite K, Mischkot P, Pianko S, Conrad A, Grint P. A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection. J Interferon Cytokine Res. 1999;19:1265-1270. [PMID: 10574619 DOI: 10.1089/107999099312939] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
8 Gish RG, Qian K, Brooks L, Leung J, Xu Y, Pike I, Lau JY. Characterization of anti-hepatitis C virus-positive sera not genotyped by restriction fragment length polymorphism or serology. J Gastroenterol Hepatol 1999;14:339-44. [PMID: 10207783 DOI: 10.1046/j.1440-1746.1999.01856.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 Al-Kubaisy W, Daud S, Al-Kubaisi MW, Al-Kubaisi OW, Abdullah NN. Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in Baghdad. J Matern Fetal Neonatal Med 2019;32:3464-9. [PMID: 29656685 DOI: 10.1080/14767058.2018.1465557] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Kuzushita N, Hayashi N, Kanto T, Takehara T, Tatsumi T, Katayama K, Ohkawa K, Ito A, Kasahara A, Moribe T. Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection. Gastroenterology. 1999;116:1149-1154. [PMID: 10220507 DOI: 10.1016/S0016-5085(99)70018-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
11 Reid AE, Koziel MJ, Aiza I, Jeffers L, Reddy R, Schiff E, Lau JY, Dienstag JL, Liang TJ. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States. Am J Gastroenterol 1999;94:1619-26. [PMID: 10364034 DOI: 10.1111/j.1572-0241.1999.01153.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
12 Ogawa E, Furusyo N, Kajiwara E, Nomura H, Kawano A, Takahashi K, Dohmen K, Satoh T, Azuma K, Nakamuta M, Koyanagi T, Kotoh K, Shimoda S, Hayashi J; The Kyushu University Liver Disease Study (KULDS) Group. Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C: Severe anemia by DAA-based triple therapy. J Gastroenterol Hepatol 2015;30:1309-16. [DOI: 10.1111/jgh.12945] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
13 Kong F, Wen X, Wen X, Wang X, Wu G, Lin S, Wang L, Xing H, Yan X, Zheng S, Ning Q, Wang Z, Zhang L, Lin J, Tong Z, Huang C, Su M, Tong L, Jia J, Xin Y, Zhu Q, Wang J, Chen L, Li X, Wu X, Niu D, Liu Q, Wei W, Zhang Y, Li G, Niu J. Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trial. J Gastroenterol Hepatol 2021. [PMID: 33491236 DOI: 10.1111/jgh.15412] [Reference Citation Analysis]
14 Vizmanos JL, González-Navarro CJ, Novo FJ, Civeira MP, Prieto J, Gullón A, García-Delgado M. Degree and distribution of variability in the 5' untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV). J Viral Hepat 1998;5:227-40. [PMID: 9751009 DOI: 10.1046/j.1365-2893.1998.00110.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
15 Terrault NA, Wright TL, Pereira BJ. HEPATITIS C INFECTION IN THE TRANSPLANT RECIPIENT. Infectious Disease Clinics of North America 1995;9:943-64. [DOI: 10.1016/s0891-5520(20)30710-8] [Cited by in Crossref: 11] [Article Influence: 0.4] [Reference Citation Analysis]
16 Othman SB, Trabelsi A, Monnet A, Bouzgarrou N, Grattard F, Beyou A, Bourlet T, Pozzetto B. Evaluation of a prototype HCV NS5b assay for typing strains of hepatitis C virus isolated from Tunisian haemodialysis patients. J Virol Methods 2004;119:177-81. [PMID: 15158600 DOI: 10.1016/j.jviromet.2004.03.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
17 Malaguarnera M, Vicari E, Calogero A, Cammalleri L, Di Fazio I, Gargante MP, Pennisi G, Risino C, Ranno S, Rampello L. Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin. J Interferon Cytokine Res. 2008;28:603-609. [PMID: 18778198 DOI: 10.1089/jir.2008.0021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kao J. Clinical relevance of hepatitis B viral genotypes: A case of déjà vu? Journal of Gastroenterology and Hepatology 2002;17:113-5. [DOI: 10.1046/j.1440-1746.2002.02623.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
19 Biasin MR, Fiordalisi G, Zanella I, Cavicchini A, Marchelle G, Infantolino D. A DNA hybridization method for typing hepatitis C virus genotype 2c. J Virol Methods 1997;65:307-15. [PMID: 9186955 DOI: 10.1016/s0166-0934(97)02202-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Nomura H, Ogo T, Rikimaru N, Ueno S, Kakuno T, Okamoto O, Shiraishi G, Kashiwagi S. Hepatitis C Virus-Related Liver Damage Is Related to Cold Activation of Complement: . Journal of Clinical Gastroenterology 1997;25:529-34. [DOI: 10.1097/00004836-199710000-00010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
21 Ogawa E, Furusyo N, Murata M, Toyoda K, Eiraku K, Shimizu M, Harada Y, Mitsumoto F, Takayama K, Okada K, Kainuma M, Hayashi J. Early phase viral kinetics of chronic hepatitis C patients receiving telaprevir-based triple therapy: A comparison of two real-time PCR assays. Antiviral Research 2013;99:119-24. [DOI: 10.1016/j.antiviral.2013.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
22 Dusheiko G, Simmonds P. Sequence variability of hepatitis C virus and its clinical relevance. Journal of Viral Hepatitis 1994;1:3-15. [DOI: 10.1111/j.1365-2893.1994.tb00057.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
23 De Mitri MS, Mele L, Chen CH, Piccinini A, Chianese R, D'Errico A, Alberti A, Pisi E. Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma. J Hepatol 1998;29:887-92. [PMID: 9875634 DOI: 10.1016/s0168-8278(98)80115-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
24 Kainuma M, Hayashi J, Sakai S, Imai K, Mantani N, Kohta K, Mitsuma T, Shimada Y, Kashiwagi S, Terasawa K. The efficacy of herbal medicine (kampo) in reducing the adverse effects of IFN-beta in chronic hepatitis C. Am J Chin Med 2002;30:355-67. [PMID: 12230024 DOI: 10.1142/S0192415X02000284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Marrone A, Sallie R. Genetic Heterogeneity of Hepatitis C Virus: The Clinical Significance of Genotypes and Quasispecies Behavior. Clinics in Laboratory Medicine 1996;16:429-49. [DOI: 10.1016/s0272-2712(18)30278-6] [Cited by in Crossref: 18] [Article Influence: 0.7] [Reference Citation Analysis]
26 McDiarmid SV, Conrad A, Ament ME, Vargas J, Martin MG, Goss JA, Busuttil RW. De novo hepatitis C in children after liver transplantation. Transplantation. 1998;66:311-318. [PMID: 9721798 DOI: 10.1097/00007890-199808150-00006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
27 Izopet J, Payen JL, Alric L, Sandres K, Charlet JP, Vinel JP, Duffaut M, Pascal JP, Puel J. Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy. J Med Virol 1998;54:86-91. [PMID: 9496364 DOI: 10.1002/(sici)1096-9071(199802)54:2<86::aid-jmv3>3.0.co;2-k] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
28 Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky J, Penin F, Sablon E, Shin-i T, Stuyver LJ, Thiel H, Viazov S, Weiner AJ, Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-73. [DOI: 10.1002/hep.20819] [Cited by in Crossref: 1016] [Cited by in F6Publishing: 972] [Article Influence: 59.8] [Reference Citation Analysis]
29 Zein NN, Persing DH, Czaja AJ. Viral genotypes as determinants of autoimmune expression in chronic hepatitis C. Mayo Clin Proc. 1999;74:454-460. [PMID: 10319074 DOI: 10.1016/s0025-6196(11)65122-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
30 Perez RM, Ferraz ML, Figueiredo MS, Contado D, Koide S, Ferreira AP, Cendoroglo Neto M, Medina Pestana JO, Silva AE. Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients. J Med Virol. 2003;69:489-494. [PMID: 12601756 DOI: 10.1002/jmv.10336] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
31 Ikezaki H, Furusyo N, Hiramine S, Ura K, Mitsumoto-Kaseida F, Takayama K, Shimizu M, Toyoda K, Ogawa E, Kainuma M, Murata M, Hayashi J. Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study. Arch Virol 2016;161:641-8. [PMID: 26660164 DOI: 10.1007/s00705-015-2703-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
32 Khattab MA, Ferenci P, Hadziyannis SJ, Colombo M, Manns MP, Almasio PL, Esteban R, Abdo AA, Harrison SA, Ibrahim N, Cacoub P, Eslam M, Lee SS. Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel. Journal of Hepatology 2011;54:1250-62. [DOI: 10.1016/j.jhep.2010.11.016] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 7.8] [Reference Citation Analysis]
33 Murakami T, Enomoto N, Kurosaki M, Izumi N, Marumo F, Sato C. Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection. Hepatology. 1999;30:1045-1053. [PMID: 10498658 DOI: 10.1002/hep.510300405] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 2.4] [Reference Citation Analysis]
34 Chan SW. Establishment of chronic hepatitis C virus infection: Translational evasion of oxidative defence. World J Gastroenterol 2014; 20(11): 2785-2800 [PMID: 24659872 DOI: 10.3748/wjg.v20.i11.2785] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
35 Dalgard O, Bjøro K, Hellum KB, Myrvang B, Ritland S, Skaug K, Raknerud N, Bell H. Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study. Hepatology. 2004;40:1260-1265. [PMID: 15558712 DOI: 10.1002/hep.20467] [Cited by in Crossref: 228] [Cited by in F6Publishing: 191] [Article Influence: 12.7] [Reference Citation Analysis]
36 Tavares RCF, Feldner ACCA, Pinho JRR, Uehara SNO, Emori CT, Carvalho-Filho RJ, Silva ISS, Santana RAF, de Castro VFD, Castoli GTF, Cristovão CU, Ferraz MLCG. Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection. Eur J Gastroenterol Hepatol 2017;29:754-8. [PMID: 28234637 DOI: 10.1097/MEG.0000000000000866] [Reference Citation Analysis]
37 Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, Kato M, Masuzawa M, Yoshihara H, Kishida Y, Shimizu Y, Inoue A, Fusamoto H, Kamada T. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial. Hepatology 1995;21:291-7. [DOI: 10.1002/hep.1840210205] [Cited by in Crossref: 81] [Cited by in F6Publishing: 60] [Article Influence: 3.0] [Reference Citation Analysis]
38 Lau JY, Simmonds P, Urdea MS. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995;346:425-6. [PMID: 7623576 DOI: 10.1016/s0140-6736(95)92786-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
39 Waki K, Sugawara Y, Tamura S, Mieno MN, Yamashiki N, Kadowaki T, Kokudo N. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data. Transplantation 2011;92:809-14. [PMID: 21832961 DOI: 10.1097/TP.0b013e31822d4dc3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
40 Narayanan Menon KV, Poterucha JJ, El-Amin OM, Burgart LJ, Kremers WK, Rosen CB, Wiesner RH, Charlton M. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. Liver Transpl. 2002;8:623-629. [PMID: 12089717 DOI: 10.1053/jlts.2002.33968] [Cited by in Crossref: 99] [Cited by in F6Publishing: 85] [Article Influence: 5.0] [Reference Citation Analysis]
41 Paterson DL, Gayowski T, Wannstedt CF, Wagener MM, Marino IR, Vargas H, Laskus T, Rakela J, Singh N. Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis 1: Quality of life with recurrent HCV. J Clin Transplan 2000;14:48-54. [DOI: 10.1034/j.1399-0012.2000.140109.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
42 Wursthorn K, Manns MP, Wedemeyer H. Natural history: the importance of viral load, liver damage and HCC. Best Pract Res Clin Gastroenterol 2008;22:1063-79. [PMID: 19187867 DOI: 10.1016/j.bpg.2008.11.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
43 Crippin JS, McCashland T, Terrault N, Sheiner P, Charlton MR. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transpl. 2002;8:350-355. [PMID: 11965579 DOI: 10.1053/jlts.2002.31748] [Cited by in Crossref: 267] [Cited by in F6Publishing: 213] [Article Influence: 13.4] [Reference Citation Analysis]
44 Oshita M, Hayashi N, Mita E, Iio S, Hiramatsu N, Hijioka T, Kato M, Masuzawa M, Sasaki Y, Kasahara A, Hori M. GBV-C/HGV infection in chronic hepatitis C patients: Its effect on clinical features and interferon therapy. J Med Virol 1998;55:98-102. [DOI: 10.1002/(sici)1096-9071(199806)55:2<98::aid-jmv3>3.0.co;2-i] [Cited by in Crossref: 13] [Article Influence: 0.5] [Reference Citation Analysis]
45 Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, Powell LW, Crawford DH. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol. 1998;28:404-409. [PMID: 9551677 DOI: 10.1016/s0168-8278(98)80313-9] [Cited by in Crossref: 82] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
46 Lefrère J. Épidémiologie descriptive de l'infection par le virus de l'hépatite C en France en 1996. Transfusion Clinique et Biologique 1997;4:299-319. [DOI: 10.1016/s1246-7820(97)80056-0] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
47 Miyayama Y, Lee H, Song H, Abe-Chayama H, Miki D, Imamura M, Chayama K, Hijikata M. Comparative study on the replication of HCV1b genome between wild-type and cell culture-adaptive mutant in regard to sensitivities against anti-HCV drugs. Microbiol Immunol 2020;64:296-303. [PMID: 31854467 DOI: 10.1111/1348-0421.12768] [Reference Citation Analysis]
48 Tibbs C. Hepatitis C. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91:121-4. [DOI: 10.1016/s0035-9203(97)90191-7] [Cited by in Crossref: 11] [Article Influence: 0.4] [Reference Citation Analysis]
49 Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynés M, Okamoto H, Bismuth H, Bréchot C. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 1995;108:1088-1096. [PMID: 7698576 DOI: 10.1016/0016-5085(95)90207-4] [Cited by in Crossref: 219] [Cited by in F6Publishing: 216] [Article Influence: 8.1] [Reference Citation Analysis]
50 Sedeño-Monge V, Laguna-Meraz S, Santos-López G, Panduro A, Sosa-Jurado F, Jose-Abrego A, Meléndez-Mena D, Muñoz-Ramírez MA, Cosme-Chávez M, Roman S. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico-A systematic review and meta-analysis (2008-2019). Ann Hepatol 2021;20:100292. [PMID: 33259949 DOI: 10.1016/j.aohep.2020.100292] [Reference Citation Analysis]
51 Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R. Multiple infections with different HCV genotypes: prevalence and clinical impact. J Clin Virol 2003;27:200-4. [PMID: 12829042 DOI: 10.1016/s1386-6532(02)00264-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
52 Simmonds P. The origin and evolution of hepatitis viruses in humans. J Gen Virol. 2001;82:693-712. [PMID: 11257174 DOI: 10.1099/0022-1317-82-4-693] [Cited by in Crossref: 155] [Cited by in F6Publishing: 151] [Article Influence: 7.4] [Reference Citation Analysis]
53 Lavillette D, Tarr AW, Voisset C, Donot P, Bartosch B, Bain C, Patel AH, Dubuisson J, Ball JK, Cosset FL. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology. 2005;41:265-274. [PMID: 15660396 DOI: 10.1002/hep.20542] [Cited by in Crossref: 203] [Cited by in F6Publishing: 205] [Article Influence: 11.9] [Reference Citation Analysis]
54 Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology. 1995;22:1050-1056. [PMID: 7557850 DOI: 10.1002/hep.1840220406] [Cited by in Crossref: 252] [Cited by in F6Publishing: 194] [Article Influence: 9.3] [Reference Citation Analysis]
55 Tarr AW, Owsianka AM, Szwejk A, Ball JK, Patel AH. Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins. Methods Mol Biol 2007;379:177-97. [PMID: 17502679 DOI: 10.1007/978-1-59745-393-6_13] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
56 Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L, Crivellaro C, Sokal E, Azzari C, Guido M, Bortolotti F. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis. 2003;36:275-280. [PMID: 12539067 DOI: 10.1086/345908] [Cited by in Crossref: 127] [Cited by in F6Publishing: 112] [Article Influence: 6.7] [Reference Citation Analysis]
57 Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology. 2006;130:231-264; quiz 214-217. [PMID: 16401486 DOI: 10.1053/j.gastro.2005.11.010] [Cited by in Crossref: 261] [Cited by in F6Publishing: 246] [Article Influence: 16.3] [Reference Citation Analysis]
58 Hassoba HM, Bzowej N, Berenguer M, Kim M, Zhou S, Phung Y, Grant R, Pessoa MG, Wright TL. Evolution of viral quasispecies in interferon-treated patients with chronic hepatitis C virus infection. J Hepatol 1999;31:618-27. [PMID: 10551384 DOI: 10.1016/s0168-8278(99)80340-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
59 Freshwater DA. Hepatitis B and C in the Armed Forces. J R Army Med Corps 2013;159:169-74. [DOI: 10.1136/jramc-2013-000096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
60 Nolte FS. Branched DNA Signal Amplification for Direct Quantitation of Nucleic Acid Sequences in Clinical Specimens. Advances in Clinical Chemistry Volume 33. Elsevier; 1998. pp. 201-35. [DOI: 10.1016/s0065-2423(08)60209-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
61 Manavi M, Baghestanian M, Watkins‐riedel T, Battistutti W, Pischinger K, Schatten C, Witschko E, Hudelist G, Hofmann H, Czerwenka K. Detection of Hepatitis C Virus (HCV) RNA in Normal Cervical Smears of HCV‐Seropositive Patients. CLIN INFECT DIS 2002;35:966-73. [DOI: 10.1086/342909] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
62 Isaacson AH, Bhardwaj B, Qian K, Davis GL, Kato T, Mizokami M, Lau JY. Hepatitis G virus infection in renal transplant recipients. J Viral Hepat. 1999;6:151-160. [PMID: 10607227 DOI: 10.1046/j.1365-2893.1999.00149.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
63 Umemura T, Alter HJ, Tanaka E, Orii K, Yeo AE, Shih JW, Matsumoto A, Yoshizawa K, Kiyosawa K. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C. Hepatology. 2002;35:953-959. [PMID: 11915044 DOI: 10.1053/jhep.2002.32536] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
64 Legrand-Abravanel F, Nicot F, Boulestin A, Sandres-Sauné K, Vinel JP, Alric L, Izopet J. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection. J Med Virol 2005;77:66-9. [PMID: 16032749 DOI: 10.1002/jmv.20414] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
65 Fanning LJ, Levis J, Kenny-Walsh E, Wynne F, Whelton M, Shanahan F. Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population. Hepatology. 2000;31:1334-1337. [PMID: 10827160 DOI: 10.1053/jhep.2000.7437] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 2.5] [Reference Citation Analysis]
66 Angelico M, Cepparulo M, Barlattani A, Liuti A, Gentile S, Hurtova M, Ombres D, Guarascio P, Rocchi G, Angelico F. Unfavourable effects of colchicine in combination with interferon-α in the treatment of chronic hepatitis C: COLCHICINE AND INTERFERON-α IN HEPATITIS C. Alimentary Pharmacology & Therapeutics 2000;14:1459-67. [DOI: 10.1046/j.1365-2036.2000.00857.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
67 Mohammed AS, Balapure A, Khan AA, Khaja MN, Ganesan R, Dutta JR. Genotyping simplified: rationally designed antisense oligonucleotide-mediated PCR amplification-free colorimetric sensing of viral RNA in HCV genotypes 1 and 3. Analyst 2021;146:4767-74. [PMID: 34231566 DOI: 10.1039/d1an00590a] [Reference Citation Analysis]
68 Simmonds P. 3 Hepatitis C virus genotypes. Hepatitis C. Elsevier; 2000. pp. 53-70. [DOI: 10.1016/s1874-5326(00)80007-1] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
69 Berg T, Hopf U, Stark K, Baumgarten R, Lobeck H, Schreier E. Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. J Hepatol. 1997;26:484-491. [PMID: 9075653 DOI: 10.1016/s0168-8278(97)80411-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
70 Haem J, Berthoux P, Mosnier JF, Grattard F, Cecillon S, Pozzetto B, Alamartine E, Berthoux F. CLEAR EVIDENCE OF THE EXISTENCE OF HEALTHY CARRIERS OF HEPATITIS C VIRUS AMONG RENAL TRANSPLANT RECIPIENTS: . Transplantation 1996;62:699,700. [DOI: 10.1097/00007890-199609150-00030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
71 Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihara A, Kiyosawa K, Okuda M, Hino K, Okita K; Osaka Liver Disease Study Group. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 1998;27:1394-402. [DOI: 10.1002/hep.510270529] [Cited by in Crossref: 326] [Cited by in F6Publishing: 297] [Article Influence: 13.6] [Reference Citation Analysis]
72 Bellobuono A, Mondazzi L, Tempini S, Chiodo F, Magliano E, Furione L, Idéo G. Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy. Journal of Hepatology 2000;33:463-8. [DOI: 10.1016/s0168-8278(00)80283-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Bréchot C. [Biology of hepatitis C viruses: clinical implications]. Rev Med Interne 1997;18:893-905. [PMID: 9499991 DOI: 10.1016/s0248-8663(97)81964-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
74 Hempel G, Galle PR, Löhr HF. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-α-treated patients with chronic hepatitis C: T Helper Cell Functions in Chronic Hepatitis C. J Med Virol 2001;64:340-9. [DOI: 10.1002/jmv.1056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
75 Iijima A, Tanaka E, Kobayashi M, Yagi S, Mizokami M, Kiyosawa K. Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum. J Gastroenterol Hepatol 2000;15:311-9. [PMID: 10764034 DOI: 10.1046/j.1440-1746.2000.02127.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
76 Charlton M, Ruppert K, Belle SH, Bass N, Schafer D, Wiesner RH, Detre K, Wei Y, Everhart J. Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database. Liver Transpl. 2004;10:1120-1130. [PMID: 15350002 DOI: 10.1002/lt.20211] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 4.6] [Reference Citation Analysis]
77 Orito E, Mizokami M, Nakano T, Terashima H, Nojiri O, Sakakibara K, Mizuno M, Ogino M, Nakamura M, Matsumoto Y. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C. J Med Virol. 1994;44:410-414. [PMID: 7897373 DOI: 10.1002/jmv.1890440418] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 1.6] [Reference Citation Analysis]
78 Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Okada K, Kainuma M, Kajiwara E, Takahashi K, Satoh T, Hayashi J. Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopenia. J Viral Hepat 2013;20:838-46. [DOI: 10.1111/jvh.12109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
79 Kato N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics. 2000;5:129-151. [PMID: 11252351 DOI: 10.1089/omi.1.2000.5.129] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 3.1] [Reference Citation Analysis]
80 Craxì A, Magrin S, Fabiano C, Linea C, Almasio P. Host and viral features in chronic HCV infection: relevance to interferon responsiveness. Res Virol 1995;146:273-8. [PMID: 8539489 DOI: 10.1016/0923-2516(96)80571-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
81 Wong DKH, Walker BD. Hepatitis C Virus. In: Mccance DJ, editor. Human Tumor Viruses. Washington: ASM Press; 1998. pp. 301-29. [DOI: 10.1128/9781555818289.ch10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
82 Tanaka E, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa K, Alter HJ. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology. 2000;32:388-393. [PMID: 10915747 DOI: 10.1053/jhep.2000.9112] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 4.3] [Reference Citation Analysis]
83 Andonov A, Chaudhary RK. Subtyping of hepatitis C virus isolates by a line probe assay using hybridization. J Clin Microbiol 1995;33:254-6. [DOI: 10.1128/jcm.33.1.254-256.1995] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
84 Pawlotsky JM, Prescott L, Simmonds P, Pellet C, Laurent-puig P, Labonne C, Darthuy F, Remire J, Duval J, Buffet C, Etienne JP, Dhumeaux D, Dussaix E. Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. J Clin Microbiol 1997;35:1734-9. [DOI: 10.1128/jcm.35.7.1734-1739.1997] [Cited by in Crossref: 50] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
85 Davis GL. Hepatitis C virus genotypes and quasispecies. Am J Med. 1999;107:21S-26S. [PMID: 10653451 DOI: 10.1016/s0002-9343(99)00376-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
86 Ramia S, Koussa S, Taher A, Haraki S, Klayme S, Sarkis D, Naman R. Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics. Ann Trop Med Parasitol. 2002;96:197-202. [PMID: 12080981 DOI: 10.1179/000349802125000439] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
87 Pereira HMDV, Cavalheiro NDP, Tengan FM, Melo CE, Mello ES, Barone AA. Patients with chronic hepatitis C and normal transaminases. Rev Inst Med trop S Paulo 2005;47:247-51. [DOI: 10.1590/s0036-46652005000500002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
88 Blum HE. Hepatitis viruses: genetic variants and clinical significance. Int J Clin Lab Res 1997;27:213-24. [DOI: 10.1007/bf02912461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
89 De Socio GVL, Francisci D, Mecozzi F, Sensini A, Polidori M, Castronari R, Pauluzzi S, Stagni G. Hepatitis C virus genotypes in the liver and serum of patients with chronic hepatitis C. Clinical Microbiology and Infection 1996;2:20-4. [DOI: 10.1111/j.1469-0691.1996.tb00195.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
90 Tahara T, Toyoda S, Mukaide M, Hikiji K, Ohba K, Mizokami M. Vertical transmission of hepatitis C through three generations. The Lancet 1996;347:409. [DOI: 10.1016/s0140-6736(96)90595-4] [Cited by in Crossref: 11] [Article Influence: 0.4] [Reference Citation Analysis]
91 Gabastou J, Manuel C, Chouaki T, Roque Afonso A, Daroukh A, Legrand S, Mahuzier G, Bourlioux P. Répartition des sérotypes du virus de l'hépatite C en fonction des modes de contamination en milieu psychiatrique. Médecine et Maladies Infectieuses 1996;26:1173-6. [DOI: 10.1016/s0399-077x(96)80116-8] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
92 Comanor L, Elkin C, Leung K, Krajden M, Kronquist K, Nicolas K, Horansky E, deMedina M, Kittichai P, Sablon E. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay. J Clin Virol. 2003;28:14-26. [PMID: 12927747 DOI: 10.1016/s1386-6532(02)00234-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
93 Abacioğlu YH, Davidson F, Simmonds P. Sequence analysis of the 5' non coding region of Turkish HCV isolates: implications for PCR diagnosis. Clin Diagn Virol 1996;5:211-4. [PMID: 15566881 DOI: 10.1016/0928-0197(96)00224-3] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
94 Zayed RA, Omran D, Zayed AA, Elmessery LO. Determinants of Infection Outcome in HCV-Genotype 4. Viral Immunol. 2017;30:560-567. [PMID: 28731371 DOI: 10.1089/vim.2017.0071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
95 Hirota M, Satoh S, Asabe S, Kohara M, Tsukiyama-Kohara K, Kato N, Hijikata M, Shimotohno K. Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation. Virology. 1999;257:130-137. [PMID: 10208927 DOI: 10.1006/viro.1999.9658] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
96 Teramura K, Fukuda A, Kobayashi H, Yoshimoto S, Kawashima H, Ohsawa N. Virus elimination and histologic improvement in patients with chronic hepatitis C treated with interferon alpha. J Clin Gastroenterol 1997;25:346-51. [PMID: 9412918 DOI: 10.1097/00004836-199707000-00011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
97 Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W, Häussinger D. Prognosis of chronic hepatitis c: Results of a large, prospective cohort study: Prognosis of Chronic Hepatitis C: Results of a Large, Prospective Cohort Study. Hepatology 1998;28:1687-95. [DOI: 10.1002/hep.510280632] [Cited by in Crossref: 436] [Cited by in F6Publishing: 404] [Article Influence: 22.9] [Reference Citation Analysis]
98 Castelain S, Zawadzki P, Khorsi H, Darchis J, Capron D, Sueur J, Eb F, Duverlie G. Comparison of hepatitis C virus serotyping and genotyping in French patients. Clinical and Diagnostic Virology 1997;7:159-65. [DOI: 10.1016/s0928-0197(96)00266-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
99 Sandres-sauné K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. Journal of Virological Methods 2003;109:187-93. [DOI: 10.1016/s0166-0934(03)00070-3] [Cited by in Crossref: 124] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
100 Mizuno Y, Suzuki K, Mori M, Hayashi K, Owaki T, Hayashi H, Kumada K, Ohba K, Mizokami M. Study of needlestick accidents and hepatitis C virus infection in healthcare workers by molecular evolutionary analysis. J Hosp Infect 1997;35:149-54. [PMID: 9049819 DOI: 10.1016/s0195-6701(97)90103-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
101 Lu L, Nakano T, Smallwood GA, Heffron TG, Robertson BH, Hagedorn CH. A refined long RT-PCR technique to amplify complete viral RNA genome sequences from clinical samples: application to a novel hepatitis C virus variant of genotype 6. J Virol Methods 2005;126:139-48. [PMID: 15847930 DOI: 10.1016/j.jviromet.2005.01.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
102 Morsica G, Bernardi MT, Novati R, Uberti Foppa C, Castagna A, Lazzarin A. Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients. J Med Virol 1997;53:252-4. [PMID: 9365891 DOI: 10.1002/(sici)1096-9071(199711)53:3<252::aid-jmv12>3.0.co;2-j] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
103 Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29:328-333. [PMID: 9918906 DOI: 10.1002/hep.510290235] [Cited by in Crossref: 427] [Cited by in F6Publishing: 394] [Article Influence: 18.6] [Reference Citation Analysis]
104 Behzadi MA, Ziyaeyan M. Hepatitis C Virus Load in Seropositive Liver and Kidney Transplant Recipients by Quantitative Real-Time PCR Before and After Transplantation. Jundishapur J Microbiol 2013;6. [DOI: 10.5812/jjm.7365] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
105 Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol. 2000;32:209-217. [PMID: 10707860 DOI: 10.1016/s0168-8278(00)80065-3] [Cited by in Crossref: 168] [Cited by in F6Publishing: 50] [Article Influence: 7.6] [Reference Citation Analysis]
106 Lyra AC, Fan X, Di Bisceglie AM. Molecular biology and clinical implication of hepatitis C virus. Braz J Med Biol Res 2004;37:691-5. [PMID: 15107931 DOI: 10.1590/s0100-879x2004000500010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
107 Khan RU, Tong CY, Bloom S, Gilmore IT, Toh CH, Bolton-Maggs PH, Beeching NJ, Hart CA. Evaluation of two simplified methods for genotyping hepatitis C virus. J Med Virol 1997;52:35-41. [PMID: 9131456 DOI: 10.1002/(sici)1096-9071(199705)52:1<35::aid-jmv7>3.0.co;2-s] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
108 Roffi L, Ricci A, Ogliari C, Scalori A, Minola E, Colloredo G, Donada C, Ceriani R, Rinaldi G, Paris B, Fornaciari G, Morales R, Del Poggio P, Sangiovanni A, Buonocore M, Bellia V, Riboli P, Nava MC, Panizzuti F, Piperno A, Pozzi M, Pioltelli P, Mancia G. HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients. J Hepatol 1998;29:701-6. [PMID: 9833906 DOI: 10.1016/s0168-8278(98)80249-3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
109 Ide T, Sata M, Sakisaka S, Nakamuta M, Fujiyama S, Mizuta T, Tahara K, Fujisaki K, Komorizono Y, Watanabe H, Morita Y, Tsubouchi H. Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan: PEG IFN RBV assessed by questionnaire. Hepatology Research 2010;40:557-65. [DOI: 10.1111/j.1872-034x.2010.00666.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
110 Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology. 1999;29:1311-1316. [PMID: 10094980 DOI: 10.1002/hep.510290424] [Cited by in Crossref: 186] [Cited by in F6Publishing: 186] [Article Influence: 8.1] [Reference Citation Analysis]
111 H. Toyoda, H. Sakamoto, T. Mizuno,. Eradication of Hepatitis C Virus 1b by Interferon in a Health Care Worker with Acute Hepatitis following Needlestick Transmission from a Patient with Chronic Hepatitis C Unresponsive to Interferon. Scandinavian Journal of Gastroenterology 2009;35:1117-20. [DOI: 10.1080/003655200451270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
112 Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol. 2010;36:91-133. [PMID: 20345213 DOI: 10.3109/10408410903357455] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 6.1] [Reference Citation Analysis]
113 Nomura H, Tsuchiya Y, Maruyama T, Miki K, Yokota T, Okubo H. The effects of a high dose, short course of interferon on hepatitis C. Journal of Gastroenterology and Hepatology 2002;14:85-9. [DOI: 10.1046/j.1440-1746.1999.01801.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
114 Fernandez I, Castellano G, Domingo MJ, Fuertes A, Colina F, Canga F, De La Cruz FJ, De La Cámara AG, Solís JA. Influence of Viral Genotype and Level of Viremia on the Severity of Liver Injury and the Response to Interferon Therapy in Spanish Patients with Chronic C Infection. Scandinavian Journal of Gastroenterology 2009;32:70-6. [DOI: 10.3109/00365529709025066] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
115 Weiner SM, Berg T, Berthold H, Weber S, Peters T, Blum HE, Hopf U, Peter HH. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. Journal of Hepatology 1998;29:375-84. [DOI: 10.1016/s0168-8278(98)80054-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
116 Fujita N, Kaito M, Takeo M, Horiike S, Tanaka H, Ikoma J, Watanabe S, Adachi Y. Different hepatitis C virus dynamics of free-virions and immune-complexes after initiation of interferon-α in patients with chronic hepatitis C. Journal of Hepatology 2003;39:1013-9. [DOI: 10.1016/s0168-8278(03)00472-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
117 Cribier B, Schmitt C, Rey D, Uhl G, Lang JM, Vetter D, Kirn A, Stoll-Keller F. HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype. Res Virol. 1997;148:267-271. [PMID: 9272577 DOI: 10.1016/s0923-2516(97)88363-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
118 Payen JL, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski JP, Seigneurin JM, Dussaix E, Voigt JJ, Selves J, Barange K, Puel J, Pascal JP. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc). Hepatology 1998;28:1680-6. [PMID: 9828235 DOI: 10.1002/hep.510280631] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
119 Mansoor S, Javed A, Ali A, Mansoor A. Heterogeneous genomic locations within NS3, NS4A and NS4B identified for genotyping and subtyping of Hepatitis C virus: A simple genome analysis approach. Infection, Genetics and Evolution 2016;44:61-8. [DOI: 10.1016/j.meegid.2016.06.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
120 Liu J, Lin H, Liu Y, Lee S, Chen Y, Hung C, Ko W, Huang C, Lai C, Chen Y, Shih Y, Chung H, Liang S, Lin J. Extremely High Prevalence and Genetic Diversity of Hepatitis C Virus Infection among HIV‐Infected Injection Drug Users in Taiwan. CLIN INFECT DIS 2008;46:1761-8. [DOI: 10.1086/587992] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
121 Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Taniai H, Okada K, Kainuma M. Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1. J Hepatol. 2012;57:534-540. [PMID: 22613000 DOI: 10.1016/j.jhep.2012.04.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
122 Ogawa E, Furusyo N, Toyoda K, Takeoka H, Maeda S, Hayashi J. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Res. 2009;83:127-134. [PMID: 19443053 DOI: 10.1016/j.antiviral.2009.04.002] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 7.4] [Reference Citation Analysis]
123 Nagayama K, Kurosaki M, Enomoto N, Miyasaka Y, Marumo F, Sato C. Characteristics of hepatitis C viral genome associated with disease progression. Hepatology 2000;31:745-50. [DOI: 10.1002/hep.510310327] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
124 Kazemi-shirazi L, Datz C, Maier-dobersberger T, Kaserer K, Hackl F, Polli C, Steindl PE, Penner E, Ferenci P. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999;116:127-34. [DOI: 10.1016/s0016-5085(99)70236-2] [Cited by in Crossref: 96] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
125 Tuveri R, Rothschild C, Pol S, Reijasse D, Persico T, Gazengel C, Bréchot C, Thiers V. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol 1997;51:36-41. [PMID: 8986947 DOI: 10.1002/(sici)1096-9071(199701)51:1<36::aid-jmv6>3.0.co;2-t] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
126 Jonas MM. VIRAL HEPATITIS. Clinics in Liver Disease 2000;4:849-77. [DOI: 10.1016/s1089-3261(05)70145-8] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
127 Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, Albertini A, Fasola M, Boffetta P, Nardi G; Brescia HCC Study. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Int J Cancer 1999;81:695-9. [DOI: 10.1002/(sici)1097-0215(19990531)81:5<695::aid-ijc4>3.0.co;2-w] [Cited by in Crossref: 93] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
128 Toyoda H, Fukuda H, Koyama Y, Takamatsu J, Saito H, Hayakawa T. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. Journal of Hepatology 1997;26:975-82. [DOI: 10.1016/s0168-8278(97)80105-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
129 Smith BC, Strasser SI, Desmond PV. Current perspectives in hepatitis C. Australian and New Zealand Journal of Medicine 1995;25:350-7. [DOI: 10.1111/j.1445-5994.1995.tb01901.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
130 Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Sone Y, Hisanaga Y. The effect of retreatment with interferon-alpha on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C. Cancer 2000;88:58-65. [PMID: 10618606 DOI: 10.1002/(sici)1097-0142(20000101)88:1<58::aid-cncr9>3.0.co;2-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
131 Kamal SM, Madwar MA, Peters T, Fawzy R, Rasenack J. Letters to the Editor. Journal of Hepatology 2000;32:172-4. [DOI: 10.1016/s0168-8278(00)80207-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
132 González-peralta RP, Fang JWS, Davis GL, Gish RG, Kohara M, Mondelli MU, Urdea MS, Mizokami M, Lau JYN. Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C. Digest Dis Sci 1995;40:2595-601. [DOI: 10.1007/bf02220447] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
133 Altuglu I, Soyler I, Ozacar T, Erensoy S. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis 2008;12:239-44. [PMID: 17942359 DOI: 10.1016/j.ijid.2007.07.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
134 Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, Coste J, Izopet J, Duverlie G, Payan C, Pawlotsky JM, Defer C, Bogard M. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat. 1999;6:435-443. [PMID: 10607261 DOI: 10.1046/j.1365-2893.1999.00187.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
135 Toyoda H, Fukuda Y, Nakano I, Katano Y, Takayama T, Kumada T, Nakano S, Takamatsu J, Saito H, Hayakawa T. Quasispecies nature of hepatitis C virus (HCV) in patients with chronic hepatitis C with mixed HCV subtypes. J Med Virol 1998;54:80-5. [DOI: 10.1002/(sici)1096-9071(199802)54:2<80::aid-jmv2>3.0.co;2-k] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
136 Amoroso P, Rapicetta M, Tosti ME, Mele A, Spada E, Buonocore S, Lettieri G, Pierri P, Chionne P, Ciccaglione AR, Sagliocca L. Correlation between virus genotype and chronicity rate in acute hepatitis C. Journal of Hepatology 1998;28:939-44. [DOI: 10.1016/s0168-8278(98)80340-1] [Cited by in Crossref: 79] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
137 Omran D, Alboraie M, Zayed RA, Wifi MN, Naguib M, Eltabbakh M, Abdellah M, Sherief AF, Maklad S, Eldemellawy HH, Saad OK, Khamiss DM, El Kassas M. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations. World J Gastroenterol 2018; 24(38): 4330-4340 [PMID: 30344418 DOI: 10.3748/wjg.v24.i38.4330] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
138 Lu L, Nakano T, Li C, Fu Y, Miller S, Kuiken C, Robertson BH, Hagedorn CH. Hepatitis C virus complete genome sequences identified from China representing subtypes 6k and 6n and a novel, as yet unassigned subtype within genotype 6. J Gen Virol 2006;87:629-34. [PMID: 16476984 DOI: 10.1099/vir.0.81400-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
139 Tanaka K, Stuver SO, Ikematsu H, Okayama A, Tachibana N, Hirohata T, Kashiwagi S, Tsubouchi H, Mueller NE. Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan. Int J Cancer 1997;72:50-5. [DOI: 10.1002/(sici)1097-0215(19970703)72:1<50::aid-ijc7>3.0.co;2-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
140 Peters T, Schlayer H, Hiller B, Rosier B, Blum H, Rasenack J. Quasispecies analysis in hepatitis C virus infection by fluorescent single strand conformation polymorphism. Journal of Virological Methods 1997;64:95-102. [DOI: 10.1016/s0166-0934(96)02144-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Sugo H, Balderson GA, Crawford DH, Fawcett J, Lynch SV, Strong RW, Futagawa S. Overseas liver transplantation for hepatitis C in Japanese patients: a comparison with patients from Australia/New Zealand. Transplant Proc 2002;34:3323-4. [PMID: 12493461 DOI: 10.1016/s0041-1345(02)03599-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Patel AH, Wood J, Penin F, Dubuisson J, McKeating JA. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J Gen Virol 2000;81:2873-83. [PMID: 11086118 DOI: 10.1099/0022-1317-81-12-2873] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 3.2] [Reference Citation Analysis]
143 Davis CL, Gretch DR, Perkins JD, Harris AW, Wener MH, Alpers CE, Lesniewski R, Lee W, dela Rosa C, Johnson RJ. Hepatitis C--associated glomerular disease in liver transplant recipients. Liver Transpl Surg 1995;1:166-75. [PMID: 9346560 DOI: 10.1002/lt.500010306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
144 Quer J, Martell M, Rodriguez F, Bosch A, Jardi R, Buti M, Esteban J. The Impact of Rapid Evolution of Hepatitis Viruses. Origin and Evolution of Viruses. Elsevier; 2008. pp. 303-49. [DOI: 10.1016/b978-0-12-374153-0.00015-1] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
145 Sagnelli E, Coppola N, Marrocco C, Onofrio M, Sagnelli C, Coviello G, Scolastico C, Filippini P. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course. J Clin Virol. 2006;35:317-320. [PMID: 16316779 DOI: 10.1016/j.jcv.2005.10.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
146 Pérez-cano R, Fernández-gutiérrez C, López-suárez A, Mira J, Girón-gonzález J. Factors related to the chronicity and evolution of hepatitis C infection in patients co-infected by the human immunodeficiency virus. Clinical Microbiology and Infection 2002;8:589-97. [DOI: 10.1046/j.1469-0691.2002.00437.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
147 Coppola N, Marrocco C, Di Caprio D, Coviello G, Scolastico C, Filippini P, Sagnelli E. Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases. Clin Infect Dis. 2003;36:528-532. [PMID: 12567314 DOI: 10.1086/367650] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
148 Lodi G, Porter S, Scully C. Hepatitis C virus infection. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 1998;86:8-22. [DOI: 10.1016/s1079-2104(98)90143-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
149 Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995;22:30-5. [DOI: 10.1002/hep.1840220106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
150 Moriyama M, Matsumura H, Shimizu T, Shioda A, Kaneko M, Miyazawa K, Miyata H, Tanaka N, Uchida T, Arakawa Y. Histopathologic impact of TT virus infection on the liver of type C chronic hepatitis and liver cirrhosis in Japan. J Med Virol. 2001;64:74-81. [PMID: 11285572 DOI: 10.1002/jmv.1020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
151 Kashiwagi K, Furusyo N, Kubo N, Nakashima H, Nomura H, Kashiwagi S, Hayashi J. A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development. J Infect Chemother 2003;9:333-40. [PMID: 14691655 DOI: 10.1007/s10156-003-0271-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
152 Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JY. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol 1995;46:109-15. [PMID: 7636496 DOI: 10.1002/jmv.1890460205] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 2.7] [Reference Citation Analysis]
153 Reiser M, Marousis CG, Nelson DR, Lauer G, González-Peralta RP, Davis GL, Lau JY. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol. 1997;26:471-478. [PMID: 9075651 DOI: 10.1016/s0168-8278(97)80409-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
154 Di Liberto G, Roque-Afonso AM, Kara R, Ducoulombier D, Fallot G, Samuel D, Feray C. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology. 2006;131:76-84. [PMID: 16831592 DOI: 10.1053/j.gastro.2006.04.016] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
155 Poterucha JJ, Gross JB. Hepatitis C After Liver Transplantation. Gastroenterology 1995;108:1314-7. [DOI: 10.1016/0016-5085(95)90236-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
156 Honda T, Katano Y, Kuzuya T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Toyoda H, Kumada T, Yamamoto K, Matsushita T, Kojima T, Takamatsu J, Goto H. Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders. J Med Virol 2013;85:228-34. [DOI: 10.1002/jmv.23444] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
157 Smith TF. SUSCEPECPTIBILITY TESTING. Infectious Disease Clinics of North America 2001;15:1263-94. [DOI: 10.1016/s0891-5520(05)70193-8] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
158 Tamalet C, Colson P, Tissot-dupont H, Henry M, Tourres C, Tivoli N, Botta D, Ravaux I, Poizot-martin I, Yahi N. Genomic and phylogenetic analysis of hepatitis C virus isolates: A survey of 535 strains circulating in southern France. J Med Virol 2003;71:391-8. [DOI: 10.1002/jmv.10505] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
159 Giannini E, Mastracci L, Botta F, Romagnoli P, Fasoli A, Risso D, Faravelli F, Ceppa P, Lantieri PB, Icardi GC. Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and alpha-glutathione S-transferase levels. Eur J Gastroenterol Hepatol. 2001;13:1355-1361. [PMID: 11692063 DOI: 10.1097/00042737-200111000-00015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
160 Fabrizi F, Lunghi G, Poordad FF, Martin P. Genetic variability of hepatitis C virus in dialysis: the implications. Int J Artif Organs 2002;25:1034-48. [PMID: 12487391 DOI: 10.1177/039139880202501102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
161 Muir P, Kämmerer U, Korn K, Mulders MN, Pöyry T, Weissbrich B, Kandolf R, Cleator GM, van Loon AM. Molecular Typing of Enteroviruses: Current Status and Future Requirements. Clin Microbiol Rev 1998;11:202-27. [DOI: 10.1128/cmr.11.1.202] [Cited by in Crossref: 182] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
162 Gretch DR, Polyak SJ, Willson RA, Carithers RL. Treatment of Chronic Hepatitis C Virus Infection: A Clinical and Virological Perspective. In: Mills J, Volberding PA, Corey L, editors. Antiviral Chemotherapy 4. Boston: Springer US; 1996. pp. 207-24. [DOI: 10.1007/978-1-4757-9209-6_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
163 Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, Tramarin A, Tositti G, Floreani A. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol. 2008;42:527-532. [PMID: 18277889 DOI: 10.1097/mcg.0b013e318030e3ab] [Cited by in Crossref: 56] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
164 Toyoda H, Kumada T, Kaneoka Y, Murakami Y. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients. J Hepatol. 2008;48:43-50. [PMID: 18023912 DOI: 10.1016/j.jhep.2007.08.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
165 Pastore L, Fiore J, Tateo M, Benedittis MD, Petruzzi M, Casalino C, Genchi C, Muzio LL, Angarano G, Serpico R. Detection of Hepatitis C Virus-RNA in Saliva from Chronically HCV-Infected Patients. Int J Immunopathol Pharmacol 2006;19:205873920601900. [DOI: 10.1177/205873920601900122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
166 Kim YJ, Kim S, Chung HJ, Jee MS, Kim BG, Kim KM, Yoon J, Lee H, Kim CY, Kim S, Yoo W, Hong SP. Population Genotyping of Hepatitis C Virus by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Analysis of Short DNA Fragments. Clinical Chemistry 2005;51:1123-31. [DOI: 10.1373/clinchem.2004.047506] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
167 Belli LS, Burra P, Poli F, Battista Alberti A, Silini E, Zavaglia C, Fagiuoli S, Prando D, Espadas de Arias A, Boninsegna S. HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation. Gastroenterology. 2006;130:695-702. [PMID: 16530511 DOI: 10.1053/j.gastro.2005.11.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
168 Cescon M, Grazi GL, Cucchetti A, Vetrone G, Ravaioli M, Ercolani G, Morelli MC, Piscaglia F, Tamè M, Pinna AD. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation. Liver Transpl. 2009;15:782-789. [PMID: 19562715 DOI: 10.1002/lt.21760] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
169 Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016; 22(34): 7824-7840 [PMID: 27678366 DOI: 10.3748/wjg.v22.i34.7824] [Cited by in CrossRef: 394] [Cited by in F6Publishing: 334] [Article Influence: 65.7] [Reference Citation Analysis]
170 Sachithanandan S, Kay E, Leader M, Fielding J. The effect of light drinking on HCV liver disease: the jury is still out. Biomedicine & Pharmacotherapy 1997;51:295-7. [DOI: 10.1016/s0753-3322(97)83546-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
171 Belli LS, Silini E, Alberti A, Bellati G, Vai C, Minola E, Rondinara G, de Carlis L, Asti M, Forti D, Ideo G. Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation. Liver Transpl Surg 1996;2:200-5. [PMID: 9346649 DOI: 10.1002/lt.500020305] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
172 Natov SN, Lau JY, Ruthazer R, Schmid CH, Levey AS, Pereira BJ. Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1999;56:700-6. [PMID: 10432411 DOI: 10.1046/j.1523-1755.1999.00594.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
173 Wu RR, Mizokami M, Lau JY, Ohno T, Fang ZX, Ohba K, Wu XS, Hata A, Sasaki M, Iino S. Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J Med Virol 1995;45:174-8. [PMID: 7775935 DOI: 10.1002/jmv.1890450211] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
174 Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int. 1997;51:981-999. [PMID: 9083262 DOI: 10.1038/ki.1997.139] [Cited by in Crossref: 273] [Cited by in F6Publishing: 236] [Article Influence: 10.9] [Reference Citation Analysis]
175 Soriuno V, Bravo R, Garcia-samaniego J, Castro A, Carballo E, González-anglada I, Martinez-odriozola P, Colmenero M, Pedreira J. Circulating Hepatitis C Virus Genotypes in Spain. Vox Sanguinis 1996;70:180-1. [DOI: 10.1111/j.1423-0410.1996.tb01320.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
176 Caraballo Cortes K, Bukowska-Ośko I, Pawełczyk A, Perlejewski K, Płoski R, Lechowicz U, Stawiński P, Demkow U, Laskus T, Radkowski M. Next-Generation Sequencing of 5' Untranslated Region of Hepatitis C Virus in Search of Minor Viral Variant in a Patient Who Revealed New Genotype While on Antiviral Treatment. Adv Exp Med Biol 2016;885:11-23. [PMID: 26747069 DOI: 10.1007/5584_2015_186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
177 Sakuma I, Enomoto N, Kurosaki M, Marumo F, Sato C. Selection of hepatitis C virus quasispecies during interferon treatment. Archives of Virology 1996;141:1921-32. [DOI: 10.1007/bf01718204] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
178 Vosnides GG. Hepatitis C in renal transplantation. Kidney Int. 1997;52:843-861. [PMID: 9291208 DOI: 10.1038/ki.1997.403] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 3.0] [Reference Citation Analysis]
179 Slowik MK, Jhaveri R. Hepatitis B and C viruses in infants and young children. Semin Pediatr Infect Dis 2005;16:296-305. [PMID: 16210109 DOI: 10.1053/j.spid.2005.06.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
180 Féray C, Shouval D, Samuel D. Will transplantation of an hepatitis C–infected graft improve the outcome of liver transplantation in HCV patients? Gastroenterology 1999;117:263-5. [DOI: 10.1016/s0016-5085(99)70577-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
181 Ferreira CT, Silveira TRD. Hepatites virais: aspectos da epidemiologia e da prevenção. Rev bras epidemiol 2004;7:473-87. [DOI: 10.1590/s1415-790x2004000400010] [Cited by in Crossref: 54] [Article Influence: 3.0] [Reference Citation Analysis]
182 Berk PD. An editor's look-back. Hepatology 2006;43:S13-30. [PMID: 16447279 DOI: 10.1002/hep.21056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
183 Yang JH, Lai JP, Douglas SD, Metzger D, Zhu XH, Ho WZ. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods. 2002;102:119-128. [PMID: 11879700 DOI: 10.1016/s0166-0934(02)00007-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
184 Martinot-Peignoux M, Boyer N, Pouteau M, Castelnau C, Giuily N, Duchatelle V, Aupérin A, Degott C, Benhamou JP, Erlinger S, Marcellin P. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J Hepatol 1998;29:214-23. [PMID: 9722202 DOI: 10.1016/s0168-8278(98)80006-8] [Cited by in Crossref: 71] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
185 Knolle PA, Kremp S, Höhler T, Krummenauer F, Schirmacher P, Gerken G. Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up. J Viral Hepat. 1998;5:399-406. [PMID: 9857349 DOI: 10.1046/j.1365-2893.1998.00127.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
186 Jonas MM, Ott MJ, Nelson SP, Badizadegan K, Perez-atayde AR. Interferon-alpha treatment of chronic hepatitis C virus infection in children: . The Pediatric Infectious Disease Journal 1998;17:241-6. [DOI: 10.1097/00006454-199803000-00013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
187 Mahmoud IM, Elhabashi AF, Elsawy E, El-husseini AA, Sheha GE, Sobh MA. The impact of hepatitis c virus viremia on renal graft and patient survival: a 9-year prospective study. American Journal of Kidney Diseases 2004;43:131-9. [DOI: 10.1053/j.ajkd.2003.09.018] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
188 Okuda K. Hepatitis C and hepatocellular carcinoma. J Gastroenterol Hepatol 1998;13:S294-7. [PMID: 28976662 DOI: 10.1111/j.1440-1746.1998.tb01896.x] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
189 Lavanchy D, Mcmahon B. 10 Worldwide prevalence and prevention of hepatitis c. Hepatitis C. Elsevier; 2000. pp. 185-IV. [DOI: 10.1016/s1874-5326(00)80014-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
190 Furusyo N, Kubo N, Nakashima H, Kashiwagi K, Etoh Y, Hayashi J. Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit. Infect Control Hosp Epidemiol. 2004;25:584-590. [PMID: 15301031 DOI: 10.1086/502443] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
191 Bassett SE, Brasky KM, Lanford RE. Analysis of Hepatitis C Virus-Inoculated Chimpanzees Reveals Unexpected Clinical Profiles. J Virol 1998;72:2589-99. [DOI: 10.1128/jvi.72.4.2589-2599.1998] [Cited by in Crossref: 114] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
192 Sears D, Davis GL. Natural History of Hepatitis C. Transplantation of the Liver. Elsevier; 2005. pp. 129-41. [DOI: 10.1016/b978-0-7216-0118-2.50014-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 Doglio A, Laffont C, Thyss S, Lefebvre J. Rapid genotyping of hepatitis C virus by direct cycle sequencing of PCR-amplified cDNAs and capillary electrophoresis analysis. Research in Virology 1998;149:219-27. [DOI: 10.1016/s0923-2516(98)80003-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
194 Oni AO, Harrison TJ. Genotypes of hepatitis C virus in Nigeria. J Med Virol 1996;49:178-86. [PMID: 8818962 DOI: 10.1002/(SICI)1096-9071(199607)49:3<178::AID-JMV4>3.0.CO;2-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
195 Fan X, Di Bisceglie AM. Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2. J Med Virol. 2001;64:325-333. [PMID: 11424122 DOI: 10.1002/jmv.1054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
196 Lu L, Li C, Fu Y, Thaikruea L, Thongswat S, Maneekarn N, Apichartpiyakul C, Hotta H, Okamoto H, Netski D, Pybus OG, Murphy D, Hagedorn CH, Nelson KE. Complete genomes for hepatitis C virus subtypes 6f, 6i, 6j and 6m: viral genetic diversity among Thai blood donors and infected spouses. J Gen Virol 2007;88:1505-18. [PMID: 17412980 DOI: 10.1099/vir.0.82604-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
197 Smith DB, Pontisso P. Heterogeneity of hepatitis C virus. Baillière's Clinical Gastroenterology 1996;10:243-55. [DOI: 10.1016/s0950-3528(96)90005-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
198 Linnen JM, Gilker J, Menez A, Vaughn A, Broulik A, Dockter J, Gillotte-taylor K, Greenbaum K, Kolk DP, Mimms LT, Giachetti C. Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification. Journal of Virological Methods 2002;102:139-55. [DOI: 10.1016/s0166-0934(02)00012-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
199 Hwang SJ, Lee SD, Lu RH, Chu CW, Wu JC, Lai ST, Chang FY. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol. 2001;65:505-509. [PMID: 11596085 DOI: 10.1002/jmv.2064] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
200 Enomoto M, Nishiguchi S, Fukuda K, Kuroki T, Tanaka M, Otani S, Ogami M, Monna T. Characteristics of patients with hepatitis C virus with and without GB virus C/Hepatitis G virus Co-infection and efficacy of interferon alfa. Hepatology 1998;27:1388-93. [DOI: 10.1002/hep.510270528] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
201 Talal AH, Shata MT, Markatou M, Dorante G, Chadburn A, Koch R, Neumann AU, Ribeiro RM, Perelson AS. Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV. J Acquir Immune Defic Syndr 2004;35:103-13. [PMID: 14722440 DOI: 10.1097/00126334-200402010-00001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
202 Sagnelli E, Imparato M, Coppola N, Pisapia R, Sagnelli C, Messina V, Piai G, Stanzione M, Bruno M, Moggio G, Caprio N, Pasquale G, Del Vecchio Blanco C. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. J Med Virol. 2008;80:1547-1553. [PMID: 18649338 DOI: 10.1002/jmv.21239] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
203 Nguyen QT, Leruez-ville M, Ferrière F, Cohen P, Roulot-marullo D, Coste T, Dény P, Guillevin L. Hepatitis C virus genotypes implicated in mixed cryoglobulinemia. J Med Virol 1998;54:20-5. [DOI: 10.1002/(sici)1096-9071(199801)54:1<20::aid-jmv4>3.0.co;2-r] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
204 Natov SN, Pereira BJ. Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients. Semin Dial 2000;13:393-8. [PMID: 11130264 DOI: 10.1046/j.1525-139x.2000.00108.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
205 Tan A, Yeh S, Liu C, Cheung C, Chen P. Viral hepatocarcinogenesis: from infection to cancer: Viral hepatocarcinogenesis. Liver International 2008;28:175-88. [DOI: 10.1111/j.1478-3231.2007.01652.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
206 Tanaka H, Tsukuma H, Kasahara A, Hayashi N, Yoshihara H, Masuzawa M, Kanda T, Kashiwagi T, Inoue A, Kato M, Oshima A, Kinoshita Y, Kamada T. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: A retrospective cohort study of 738 patients. Int J Cancer 2000;87:741-9. [DOI: 10.1002/1097-0215(20000901)87:5<741::aid-ijc18>3.0.co;2-b] [Cited by in Crossref: 63] [Article Influence: 2.9] [Reference Citation Analysis]
207 Sánchez-tapias J, Rodés J. Dilemmas of organ transplantation from anti-HCV-positive donors. The Lancet 1995;345:469-70. [DOI: 10.1016/s0140-6736(95)90579-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
208 Bréchot C. Hepatitis C virus: Molecular biology and genetic variability. Digest Dis Sci 1996;41:6S-21S. [DOI: 10.1007/bf02087872] [Cited by in Crossref: 40] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
209 Kleter GE, van Doorn LJ, Stuyver L, Maertens G, Brouwer JT, Schalm SW, Heijtink RA, Quint WG. Rapid genotyping of hepatitis C virus RNA-isolates obtained from patients residing in western Europe. J Med Virol. 1995;47:35-42. [PMID: 8551256 DOI: 10.1002/jmv.1890470108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
210 Ohkawa K, Yuki N, Kanazawa Y, Ueda K, Mita E, Sasaki Y, Kasahara A, Hayashi N. Cleavage of viral RNA and inhibition of viral translation by hepatitis C virus RNA-specific hammerhead ribozyme in vitro. J Hepatol. 1997;27:78-84. [PMID: 9252077 DOI: 10.1016/s0168-8278(97)80283-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
211 Féray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, Loinaz C, Gigou M, Burra P, Barkholt L. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology. 1999;117:619-625. [PMID: 10464137 DOI: 10.1016/s0016-5085(99)70454-3] [Cited by in Crossref: 283] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
212 Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, Gown A, Frank I, Perkins JD, Carithers RL. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology. 1995;22:1-9. [PMID: 7601397 DOI: 10.1002/hep.1840220102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
213 Bernier L, Willems B, Delage G, Murphy DG. Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol 1996;34:2815-8. [DOI: 10.1128/jcm.34.11.2815-2818.1996] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
214 Darweesh SK, Elsaeed K, Omar H, El Raziky M, Elakel W, Elserafy M, Ismail SA, Gomaa AA, Mehrez M, El Kassas M, Abdullah M, Shaker MK, Esmat G, El Shazly Y, Doss W, Waked I. High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study. Expert Rev Gastroenterol Hepatol 2019;13:907-14. [PMID: 31173527 DOI: 10.1080/17474124.2019.1629287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
215 Mendel I, Clotteau L, Lambed S, Buffet-janvresse C. Hepatitis C virus infection in an HIV-positive population in normandy: Antibodies, HCV RNA and genotype prevalence. J Med Virol 1995;47:231-6. [DOI: 10.1002/jmv.1890470308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
216 Kanto T, Hayashi N, Takehara T, Katayama K, Kato M, Akiyama M, Kasahara A, Fusamoto H, Kamada T. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients. J Med Virol 1996;50:126-34. [DOI: 10.1002/(sici)1096-9071(199610)50:2<126::aid-jmv5>3.0.co;2-c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
217 Hwang SJ, Luo JC, Chu CW, Lai CR, Lu CL, Tsay SH, Wu JC, Chang FY, Lee SD. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol. 2001;16:190-195. [PMID: 11207900 DOI: 10.1046/j.1440-1746.2001.02407.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 5.3] [Reference Citation Analysis]
218 Mullan B, Kenny-Walsh E, Collins JK, Shanahan F, Fanning LJ. Inferred hepatitis C virus quasispecies diversity is influenced by choice of DNA polymerase in reverse transcriptase-polymerase chain reactions. Anal Biochem 2001;289:137-46. [PMID: 11161307 DOI: 10.1006/abio.2000.4946] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
219 Watanabe H, Nagayama K, Enomoto N, Itakura J, Tanabe Y, Hamano K, Izumi N, Sato C, Watanabe M. Sequence elements correlating with circulating viral load in genotype 1b hepatitis C virus infection☆. Virology 2003;311:376-83. [DOI: 10.1016/s0042-6822(03)00155-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
220 Cowan ML, Maxwell JD. Treatment of hepatitis C virus infection in intravenous drug users. Acta Neuropsychiatr 2006;18:183-92. [DOI: 10.1111/j.1601-5215.2006.00136.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
221 Müller Z, Deák J, Ross R, Nagy E, Kovács L, Roggendorf M, Kessler HH. Hepatitis C virus genotypes in Hungarian and Austrian patients with chronic hepatitis C. Journal of Clinical Virology 2003;26:295-300. [DOI: 10.1016/s1386-6532(02)00045-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
222 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
223 Mendel I, Muraine M, Riachi G, el Forzli F, Bertin C, Colin R, Brasseur G, Buffet-Janvresse C. Detection and genotyping of the hepatitis C RNA in tear fluid from patients with chronic hepatitis C. J Med Virol 1997;51:231-3. [PMID: 9139089 DOI: 10.1002/(sici)1096-9071(199703)51:3<231::aid-jmv15>3.0.co;2-n] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
224 Watson JP, Al-mardini H, Awadh S, Ukabam S, Record CO. Hepatitis C Virus Genotypes in a Cohort of Middle Eastern Patients. Ann Saudi Med 1999;19:410-2. [DOI: 10.5144/0256-4947.1999.410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
225 Hagiwara H, Hayashi N, Mita E, Oshita M, Kobayashi I, Iio S, Hiramatsu N, Sasaki Y, Kasahara A, Kakinuma K, Yamauchi T, Fusamoto H. Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C. J Viral Hepat. 1999;6:463-469. [PMID: 10607265 DOI: 10.1046/j.1365-2893.1999.00183.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
226 Bendinelli M, Vatteroni ML, Maggi F, Pistello M. Hepatitis C Virus. In: Specter S, editor. Viral Hepatitis. Totowa: Humana Press; 1999. pp. 65-127. [DOI: 10.1007/978-1-59259-702-4_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
227 De Mitri MS, Mele L, Morsica G, Chen CH, Sitia G, Gramenzi A, Andreone P, Alberti A, Bernardi M, Pisi E. Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies. J Med Virol 2000;60:133-8. [DOI: 10.1002/(sici)1096-9071(200002)60:2<133::aid-jmv5>3.0.co;2-q] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
228 Seme K, Poljak M, Les˘nic˘ar G, Brinovec V, S˘tepec S, Koren S. Distribution of Hepatitis C Virus Genotypes in Slovenia. Scandinavian Journal of Infectious Diseases 2009;29:29-31. [DOI: 10.3109/00365549709008660] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
229 Penin F. Structural biology of hepatitis C virus. Clin Liver Dis. 2003;7:1-21, vii. [PMID: 12691456 DOI: 10.1016/s1089-3261(02)00066-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
230 Rigamonti C, Andorno S, Maduli E, Morelli S, Pittau S, Nicosia G, Boldorini R, Sartori M. Iron, hepatic stellate cells and fibrosis in chronic hepatitis C. Eur J Clin Invest. 2002;32 Suppl 1:28-35. [PMID: 11886429 DOI: 10.1046/j.1365-2362.2002.0320s1028.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
231 Hügle T, Cerny A. Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. Rev Med Virol 2003;13:361-71. [PMID: 14625884 DOI: 10.1002/rmv.397] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
232 Kurihara C, Ishiyama N, Nishiyama Y, Fukushi S, Kageyama T, Katayama K, Miura S. Molecular characterization of hepatitis C virus genotype 2a from the entire sequences of four isolates. J Med Virol 2001;64:466-75. [DOI: 10.1002/jmv.1073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
233 Chin M, Hogan C, Nguyen D. The Natural History of Hepatit is C Viral Infection: Clinical Evaluation and Monitoring. MEDJ 2016;3:52-7. [DOI: 10.2174/1874220301603010052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
234 Sagnelli E, Coppola N, Marrocco C, Coviello G, Battaglia M, Messina V, Rossi G, Sagnelli C, Scolastico C, Filippini P. Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. J Hepatol. 2005;42:646-651. [PMID: 15826712 DOI: 10.1016/j.jhep.2004.12.027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
235 Pawlotsky J, Darthuy F, Rémiré J, Pellet C, Udin L, Stuyver L, Roudot-thoraval F, Duvoux C, Douvin C, Mallat A, Mavier J, Métreau J, Duval J, Dhumeaux D. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. J Med Virol 1995;47:285-91. [DOI: 10.1002/jmv.1890470316] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
236 Davalieva K, Kiprijanovska S, Plaseska-Karanfilska D. Fast, reliable and low cost user-developed protocol for detection, quantification and genotyping of hepatitis C virus. J Virol Methods 2014;196:104-12. [PMID: 24269794 DOI: 10.1016/j.jviromet.2013.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
237 Germer JJ, Zein NN. Advances in the molecular diagnosis of hepatitis C and their clinical implications. Mayo Clin Proc. 2001;76:911-920. [PMID: 11560302 DOI: 10.1016/s0025-6196(11)62111-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
238 Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, Bellobuono A, Mondelli MU. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. Journal of Hepatology 1995;22:691-5. [DOI: 10.1016/0168-8278(95)80225-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 1.9] [Reference Citation Analysis]
239 Touceda S, Pereira M, Agulla A. [Prevalence of hepatitis C virus genotypes in the area of El Ferrol (La Coruña, Spain)]. Enferm Infecc Microbiol Clin 2002;20:200-4. [PMID: 12006256 DOI: 10.1016/s0213-005x(02)72789-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
240 Castelain S, Khorsi H, Zawadzki P, Sueur J, Capron J, Eb F, Duverlie G. Direct blotting electrophoresis for sequencing and genotyping hepatitis C virus. Journal of Virological Methods 1997;65:237-43. [DOI: 10.1016/s0166-0934(97)02184-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
241 van der Poel C, Reesink H, Cuypers H. Hepatitis C virus six years on. The Lancet 1994;344:1475-9. [DOI: 10.1016/s0140-6736(94)90293-3] [Cited by in Crossref: 120] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
242 Rostaing L, Izopet J, Cisterne J, Arnaud C, Duffaut M, Rumeau J, Puel J, Durand D. IMPACT OF HEPATITIS C VIRUS DURATION AND HEPATITIS C VIRUS GENOTYPES ON RENAL TRANSPLANT PATIENTS: Correlation with Clinicopathological Features. Transplantation 1998;65:930-6. [DOI: 10.1097/00007890-199804150-00012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
243 Salvatierra K, Florez H. Análisis del virus de la hepatitis C en pacientes en hemodiálisis. Infectio 2016;20:130-7. [DOI: 10.1016/j.infect.2015.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
244 Jacobson KR, Murray K, Zellos A, Schwarz KB. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr. 2002;34:52-58. [PMID: 11753165 DOI: 10.1097/00005176-200201000-00013] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
245 Ishikawa T, Abe S, Kojima Y, Kojima S, Yoshida T. Discrepant diagnostic results using two genotyping methods in a chronic hepatitis C patient in serogroup 1: Discrepant genotyping HCV results. Hepatol Res 2016;46:354-6. [DOI: 10.1111/hepr.12536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
246 Pentón N, Musacchio A, Rivera J, Roca J, Ponce M, Rodríguez D, Caballero A, Tallo Y, Narciandi R. Antigenicity of a recombinant NS3 protein representative of ATPase/helicase domain from hepatitis C virus. Clinical Biochemistry 2003;36:41-9. [DOI: 10.1016/s0009-9120(02)00365-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
247 Himoto T, Tani J, Miyoshi H, Yoneyama H, Mori H, Inukai M, Masugata H, Goda F, Senda S, Haba R, Masaki T. The ratio of insulin-like growth factor-I/insulin-like growth factor–binding protein-3 in sera of patients with hepatitis C virus–related chronic liver disease as a predictive marker of insulin resistance. Nutrition Research 2013;33:27-33. [DOI: 10.1016/j.nutres.2012.11.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
248 Fan Z, Zhang Q, Chen H, He P, Li Y, Si M, Jiao X. Circulating microRNAs as a biomarker to predict therapy efficacy in hepatitis C patients with different genotypes. Microb Pathog 2017;112:320-6. [PMID: 28993299 DOI: 10.1016/j.micpath.2017.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
249 Martin P, Carter D, Fabrizi F, Dixit V, Conrad AJ, Artinian L, Peacock V, Han S, Wilkinson A, Lassman CR. Histopathological features of hepatitis C in renal transplant candidates [see comment]. Transplantation. 2000;69:1479-1484. [PMID: 10798774 DOI: 10.1097/00007890-200004150-00045] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 4.2] [Reference Citation Analysis]
250 Fang JW, Chow V, Lau JY. VIROLOGY OF HEPATITIS C VIRUS. Clinics in Liver Disease 1997;1:493-514. [DOI: 10.1016/s1089-3261(05)70317-2] [Cited by in Crossref: 18] [Article Influence: 0.7] [Reference Citation Analysis]
251 Yamashita T, Kaneko S, Shirota Y, Qin W, Nomura T, Kobayashi K, Murakami S. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J Biol Chem 1998;273:15479-86. [PMID: 9624134 DOI: 10.1074/jbc.273.25.15479] [Cited by in Crossref: 180] [Cited by in F6Publishing: 164] [Article Influence: 7.5] [Reference Citation Analysis]
252 Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol. 2003;38:335-342. [PMID: 12586300 DOI: 10.1016/s0168-8278(02)00415-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
253 Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology. 2000;32:1106-1110. [PMID: 11050062 DOI: 10.1053/jhep.2000.19288] [Cited by in Crossref: 157] [Cited by in F6Publishing: 155] [Article Influence: 7.1] [Reference Citation Analysis]
254 Kazemi-Shirazi L, Petermann D, Müller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol. 2000;33:785-790. [PMID: 11097488 DOI: 10.1016/s0168-8278(00)80311-6] [Cited by in Crossref: 58] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
255 Alonso PA, Orduña A, Miguel AS, Dominguez E, Bratos M, Gutierrez M, Eiros J, Inglada L, Hernandez JMG, Torres AR. Relation of hepatitis C virus genotypes to risk factors and hepatic disease in Spanish patients. Clinical Microbiology and Infection 1997;3:647-52. [DOI: 10.1111/j.1469-0691.1997.tb00472.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
256 Gremion C, Cerny A. Hepatitis C virus and the immune system: a concise review. Rev Med Virol. 2005;15:235-268. [PMID: 15782389 DOI: 10.1002/rmv.466] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
257 Chayama K, Hayes CN. Hepatitis C virus: How genetic variability affects pathobiology of disease. J Gastroenterol Hepatol. 2011;26 Suppl 1:83-95. [PMID: 21199518 DOI: 10.1111/j.1440-1746.2010.06550.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
258 Giannini C, Giannelli F, Monti M, Careccia G, Marrocchi ME, Laffi G, Gentilini P, Zignego AL. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med. 1999;134:68-73. [PMID: 10402061 DOI: 10.1016/s0022-2143(99)90055-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
259 Bertuzzo VR, Cescon M, Morelli MC, Di Gioia P, Tamè M, Lorenzini S, Andreone P, Ercolani G, Del Gaudio M, Ravaioli M. Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. Dig Liver Dis. 2012;44:861-867. [PMID: 22819767 DOI: 10.1016/j.dld.2012.06.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
260 Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl. 2002;8:362-369. [PMID: 11965581 DOI: 10.1053/jlts.2002.32282] [Cited by in Crossref: 193] [Cited by in F6Publishing: 169] [Article Influence: 9.7] [Reference Citation Analysis]
261 Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Mem Inst Oswaldo Cruz. 2003;98:599-603. [PMID: 13677340 DOI: 10.1590/s0074-02762003000500003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
262 Fonseca JCFD, Brasil LM. Infecção pelo vírus da hepatite C na região Amazônica brasileira. Rev Soc Bras Med Trop 2004;37:1-8. [DOI: 10.1590/s0037-86822004000700001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
263 Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology. 1999;30:595-601. [PMID: 10462362 DOI: 10.1002/hep.510300312] [Cited by in Crossref: 314] [Cited by in F6Publishing: 306] [Article Influence: 13.7] [Reference Citation Analysis]
264 Dentico P, Curatolo N, Sacco R, De Luca M, Volpe A, Ranieri C, Genchi C, Petracca L, Buongiorno R. Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical Area in southeast Italy. Infection 1999;27:118-21. [DOI: 10.1007/bf02560510] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
265 Lunel F, Stuyver L, Brechot C, Maertens G. [Update on hepatitis C virus: its variability and the implications]. Transfus Clin Biol 1998;5:147-65. [PMID: 9618840 DOI: 10.1016/s1246-7820(98)80005-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
266 Orlacchio A, Bolacchi F, Cadioli M, Bergamini A, Cozzolino V, Angelico M, Simonetti G. Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy. AJR Am J Roentgenol 2008;190:1331-9. [PMID: 18430852 DOI: 10.2214/AJR.07.2262] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
267 Cai Q, Zhang X, Tian L, Yuan M, Jin G, Lu Z. Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China. J Med Virol. 2002;67:490-500. [PMID: 12115994 DOI: 10.1002/jmv.10128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
268 Ogawa E, Furusyo N, Kajiwara E, Nomura H, Kawano A, Takahashi K, Dohmen K, Satoh T, Azuma K, Nakamuta M. Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection. J Gastroenterol Hepatol. 2015;30:1759-1767. [PMID: 26095167 DOI: 10.1111/jgh.13016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
269 Franchini M, Rossetti G, Tagliaferri A, Capra F, de Maria E, Pattacini C, Lippi G, Lo Cascio G, de Gironcoli M, Gandini G. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 2001;98:1836-41. [DOI: 10.1182/blood.v98.6.1836] [Cited by in Crossref: 60] [Cited by in F6Publishing: 5] [Article Influence: 2.9] [Reference Citation Analysis]
270 Mabee CL, Crippin JS, Lee WM. Review article: interferon and hepatitis C--factors predicting therapeutic outcome. Aliment Pharmacol Ther 1998;12:509-18. [PMID: 9678809 DOI: 10.1046/j.1365-2036.1998.00328.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
271 Roffi L, Redaelli A, Colloredo G, Minola E, Donada C, Picciotto A, Riboli P, Del Poggio P, Rinaldi G, Paris B. Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype. Eur J Gastroenterol Hepatol. 2001;13:501-506. [PMID: 11396528 DOI: 10.1097/00042737-200105000-00007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
272 Kuzushita N, Hayashi N, Katayama K, Hiramatsu N, Yasumaru M, Murata H, Shimizu Y, Yamazaki T, Fushimi H, Kotoh K, Kasahara A, Fusamoto H, Kamada T. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. J Med Virol 1996;48:1-7. [DOI: 10.1002/(sici)1096-9071(199601)48:1<1::aid-jmv1>3.0.co;2-e] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
273 Yamaji K, Hayashi J, Kawakami Y, Furusyo N, Sawayama Y, Kishihara Y, Etoh Y, Kashiwagi S. Hepatitis C Viral RNA Status at Two Weeks of Therapy Predicts the Eventual Response: . Journal of Clinical Gastroenterology 1998;26:193-9. [DOI: 10.1097/00004836-199804000-00009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
274 Mamun-al-mahtab, Rahman S, Khan M, Karim F, Sharif NM, Shrestha A. Genotypes of HCV in Bangladesh: Experience from a Tertiary Centre. Hungarian Medical Journal 2008;2:577-81. [DOI: 10.1556/hmj.2.2008.4.9] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
275 Guido M, Rugge M, Thung SN, Chemello L, Leandro G, Alberti A, Cecchetto A, Pontisso P, Cavalletto L, Ninfo V. Hepatitis C virus serotypes and liver pathology. Liver 1996;16:353-7. [DOI: 10.1111/j.1600-0676.1996.tb00761.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
276 Bellobuono A, Mondazzi L, Tempini S, Chiodo F, Magliano E, Mondini C, Idéo G. Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months? Journal of Hepatology 1999;30:8-13. [DOI: 10.1016/s0168-8278(99)80002-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
277 González-pérez MA, Norder H, Bergström Å, Lopéz E, Visoná KA, Magnius LO. High prevalence of GB virus C strains genetically related to strains with Asian origin in Nicaraguan hemophiliacs. J Med Virol 1997;52:149-55. [DOI: 10.1002/(sici)1096-9071(199706)52:2<149::aid-jmv5>3.0.co;2-3] [Cited by in Crossref: 22] [Article Influence: 0.9] [Reference Citation Analysis]
278 Paulson MS, Yang H, Shih IH, Feng JY, Mabery EM, Robinson MF, Zhong W, Delaney WE 4th. Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus. Antiviral Res 2009;83:135-42. [PMID: 19457562 DOI: 10.1016/j.antiviral.2009.04.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
279 Poovorawan Y, Chatchatee P, Chongsrisawat V. Epidemiology and prophylaxis of viral hepatitis:A global perspective: Epidemiology and prophylaxis of viral hepatitis. Journal of Gastroenterology and Hepatology 2002;17:S155-66. [DOI: 10.1046/j.1440-1746.17.s1.4.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
280 Panigrahi AK, Roca J, Acharya SK, Jameel S, Panda SK. Genotype determination of hepatitis C virus from Northern India: Identification of a new subtype. J Med Virol 1996;48:191-8. [DOI: 10.1002/(sici)1096-9071(199602)48:2<191::aid-jmv12>3.0.co;2-i] [Cited by in Crossref: 42] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
281 Sagnelli E, Pasquale G, Coppola N, Marrocco C, Scarano F, Imparato M, Sagnelli C, Scolastico C, Piccinino F. Liver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitis. J Med Virol 2005;75:222-6. [DOI: 10.1002/jmv.20260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
282 Lyra AC, Fan X, Lang DM, Yusim K, Ramrakhiani S, Brunt EM, Korber B, Perelson AS, Di Bisceglie AM. Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology 2002;123:1485-93. [PMID: 12404223 DOI: 10.1053/gast.2002.36546] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 2.3] [Reference Citation Analysis]
283 Baker RI, Smith J, Eikelboom J, Leahy B, Kay I, Lavis N, Palladino S, Cheng W, Price J, Mews C. Hepatitis C genotypes in Australian haemophilia patients. Australian and New Zealand Journal of Medicine 1996;26:789-92. [DOI: 10.1111/j.1445-5994.1996.tb00626.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
284 Shobokshi OA, Serebour FE, Skakni L, Al-saffy YH, Ahdal MN. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 1999;58:44-8. [DOI: 10.1002/(sici)1096-9071(199905)58:1<44::aid-jmv6>3.0.co;2-u] [Cited by in Crossref: 48] [Article Influence: 2.1] [Reference Citation Analysis]
285 Ohba K, Mizokami M, Ohno T, Suzuki K, Orito E, Ina Y, Lau JY, Gojobori T. Classification of hepatitis C virus into major types and subtypes based on molecular evolutionary analysis. Virus Res 1995;36:201-14. [PMID: 7653099 DOI: 10.1016/0168-1702(95)00007-d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
286 Norder H, Bergström Å, Uhnoo I, Aldén J, Weiss L, Czajkowski J, Magnius L. Confirmation of Nosocomial Transmission of Hepatitis C Virus by Phylogenetic Analysis of the NS5-B Region. J Clin Microbiol 1998;36:3066-9. [DOI: 10.1128/jcm.36.10.3066-3069.1998] [Cited by in Crossref: 64] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
287 Doi H, Apichartpiyakul C, Ohba KI, Mizokami M, Hotta H. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 1996;34:569-74. [DOI: 10.1128/jcm.34.3.569-574.1996] [Cited by in Crossref: 45] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
288 Befrits R, Hedman M, Blomquist L, Allander T, Grillner L, Kinnman N, Rubio C, Hultcrantz R. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease. Scand J Gastroenterol. 1995;30:1113-1118. [PMID: 8578173 DOI: 10.3109/00365529509101616] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 2.3] [Reference Citation Analysis]
289 Nyan DC, Swinson KL. A method for rapid detection and genotype identification of hepatitis C virus 1-6 by one-step reverse transcription loop-mediated isothermal amplification. Int J Infect Dis 2016;43:30-6. [PMID: 26686938 DOI: 10.1016/j.ijid.2015.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
290 Hayashi K, Fukuda Y, Nakano I, Katano Y, Yokozaki S, Toyoda H, Takamatsu J, Hayakawa T. Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus-infected haemophiliacs. Haemophilia 2000;6:677-81. [PMID: 11122395 DOI: 10.1046/j.1365-2516.2000.00444.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
291 Seong YR, Choi S, Lim JS, Lee CH, Lee CK, Im DS. Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses. Vaccine 2001;19:2955-64. [PMID: 11282207 DOI: 10.1016/s0264-410x(00)00534-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
292 Aitken C, McCaw R, Jardine D, Bowden S, Higgs P, Nguyen O, Crofts N, Hellard M. Change in hepatitis C virus genotype in injecting drug users. J Med Virol 2004;74:543-5. [PMID: 15484265 DOI: 10.1002/jmv.20212] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
293 Raghuraman S, Shaji R, Sridharan G, Radhakrishnan S, Chandy G, Ramakrishna B, Abraham P. Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. Journal of Clinical Virology 2003;26:61-9. [DOI: 10.1016/s1386-6532(02)00025-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
294 Sheiner PA, Boros P, Klion FM, Thung SN, Schluger LK, Lau JY, Mor E, Bodian C, Guy SR, Schwartz ME. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology. 1998;28:831-838. [PMID: 9731580 DOI: 10.1002/hep.510280334] [Cited by in Crossref: 177] [Cited by in F6Publishing: 149] [Article Influence: 7.4] [Reference Citation Analysis]
295 Jackson P, Petrik J, Alexander GJ, Pearson G, Allain JP. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma. J Med Virol 1997;51:67-79. [PMID: 8986952 DOI: 10.1002/(sici)1096-9071(199701)51:1<67::aid-jmv11>3.0.co;2-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
296 Rostaing L, Izopet J, Arnaud C, Cisterne J, Alric L, Rumeau J, Duffaut M, Durand D. LONG-TERM IMPACT OF SUPERINFECTION BY HEPATITIS G VIRUS IN HEPATITIS C VIRUS-POSITIVE RENAL TRANSPLANT PATIENTS: . Transplantation 1999;67:556-60. [DOI: 10.1097/00007890-199902270-00012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
297 Neuman MG, Monteiro M, Rehm J. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Subst Use Misuse 2006;41:1395-463. [PMID: 17002989 DOI: 10.1080/10826080600846235] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
298 Bruno S, Battezzati PM, Bellati G, Manzin A, Maggioni M, Crosignani A, Borzio M, Solforosi L, Morabito A, Ideo G. Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol. 2001;34:748-755. [PMID: 11434622 DOI: 10.1016/s0168-8278(01)00062-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
299 Lasarte J, García-granero M, López A, Casares N, García N, Civeira M, Borrás-cuesta F, Prieto J. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C: Cellular Immunity to Hepatitis C Virus Core Protein and the Response to Interferon in Patients With Chronic Hepatitis C. Hepatology 1998;28:815-22. [DOI: 10.1002/hep.510280332] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 3.6] [Reference Citation Analysis]
300 Giangrande PL. Hepatitis in haemophilia. Br J Haematol 1998;103:1-9. [PMID: 9792281 DOI: 10.1046/j.1365-2141.1998.00855.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
301 Toniutto P, Pirisi M, Tisminetzky SG, Fabris C, Chinellato E, Gerotto M, Falleti E, Ferroni P, Lombardelli T, Bartoli E, Baralle F. Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions. J Clin Microbiol 1996;34:2382-5. [DOI: 10.1128/jcm.34.10.2382-2385.1996] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
302 Malaguarnera M, Vacante M, Bertino G, Neri S, Malaguarnera M, Gargante MP, Motta M, Lupo L, Chisari G, Bruno CM. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin. J Interferon Cytokine Res. 2011;31:653-659. [PMID: 21923249 DOI: 10.1089/jir.2011.0010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
303 Lau JY, Fang JW, Mizokami M, Gish RG, Wright TL. Hepatitis C. In: Runge MS, Patterson C, editors. Principles of Molecular Medicine. Totowa: Humana Press; 2006. pp. 542-53. [DOI: 10.1007/978-1-59259-963-9_52] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
304 Kleter B, Brouwer JT, Nevens F, van Doorn LJ, Elewaut A, Versieck J, Michielsen PP, Hautekeete ML, Chamuleau RA, Brénard R, Bourgeois N, Adler M, Quint WG, Bronkhorst CM, Heijtink RA, Hop WJ, Fevery J, Schalm SW. Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. Liver 1998;18:32-8. [PMID: 9548265 [PMID: 9548265 DOI: 10.1111/j.1600-0676.1998.tb00124.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
305 Pessôa MG, Alves VA, Wakamatsu A, Gomes JG, Maertens G, van der Borght B, Kim M, Ferrell L, Wright TL. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications. Liver Int 2008;28:807-13. [PMID: 18422936 DOI: 10.1111/j.1478-3231.2008.01739.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
306 Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients. J Med Virol 1996;48:354-9. [PMID: 8699168 DOI: 10.1002/(SICI)1096-9071(199604)48:4<354::AID-JMV9>3.0.CO;2-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
307 Coppola N, Pisapia R, Marrocco C, Martini S, Vatiero LM, Messina V, Tonziello G, Sagnelli C, Filippini P, Piccinino F. Anti-HCV IgG avidity index in acute hepatitis C. J Clin Virol. 2007;40:110-115. [PMID: 17720621 DOI: 10.1016/j.jcv.2007.07.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
308 Vivarelli M, Burra P, La Barba G, Canova D, Senzolo M, Cucchetti A, D’Errico A, Guido M, Merenda R, Neri D. Influence of steroids on HCV recurrence after liver transplantation: A prospective study. J Hepatol. 2007;47:793-798. [PMID: 17928091 DOI: 10.1016/j.jhep.2007.07.023] [Cited by in Crossref: 83] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
309 Mettikanont P, Bunchorntavakul C, Reddy KR. Systematic review: epidemiology and response to direct-acting antiviral therapy in genotype 6 chronic hepatitis C virus infection. Aliment Pharmacol Ther 2019;49:492-505. [PMID: 30687952 DOI: 10.1111/apt.15100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
310 Hatzakis A, Katsoulidou A, Kaklamani E, Touloumi G, Koumantaki Y, Tassopoulos NC, Karvountzis G, Gioustozi A, Hadziyannis S, Trichopoulos D. Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study. Int J Cancer 1996;68:51-3. [PMID: 8895540 DOI: 10.1002/(SICI)1097-0215(19960927)68:1<51::AID-IJC10>3.0.CO;2-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
311 Crone C, Gabriel GM. Comprehensive review of hepatitis C for psychiatrists: risks, screening, diagnosis, treatment, and interferon-based therapy complications. J Psychiatr Pract. 2003;9:93-110. [PMID: 15985921 DOI: 10.1097/00131746-200303000-00002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
312 Abe S, Narita R, Matsuhashi T, Oto T, Tabaru A, Otsuki M. Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C: . European Journal of Gastroenterology & Hepatology 2008;20:373-8. [DOI: 10.1097/meg.0b013e3282f43aae] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
313 Bevilacqua E, Fabris A, Floreano P, Pembrey L, Newell ML, Tovo PA, Amoroso A. Genetic factors in mother-to-child transmission of HCV infection. Virology. 2009;390:64-70. [PMID: 19481774 DOI: 10.1016/j.virol.2009.05.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
314 Ogawa E, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Maruyama T, Tanabe Y, Satoh T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group. Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study. J Hepatol. 2013;58:495-501. [PMID: 23099187 DOI: 10.1016/j.jhep.2012.10.017] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 9.3] [Reference Citation Analysis]
315 Canchis PW, Yee HT, Fiel MI, Dieterich DT, Liu R, Chiriboga L, Jacobson IM, Edlin BR, Talal AH. Intrahepatic CD4+ Cell Depletion in Hepatitis C Virus/HIV???Coinfected Patients: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2004;37:1125-31. [DOI: 10.1097/01.qai.0000131937.52106.92] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
316 Izopet J, Sandres-Sauné K, Kamar N, Salama G, Dubois M, Pasquier C, Rostaing L. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol. 2005;77:70-76. [PMID: 16032714 DOI: 10.1002/jmv.20415] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 3.8] [Reference Citation Analysis]
317 González-Peralta RP, Qian K, She JY, Davis GL, Ohno T, Mizokami M, Lau JY. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol 1996;49:242-7. [PMID: 8818972 DOI: 10.1002/(SICI)1096-9071(199607)49:3<242::AID-JMV14>3.0.CO;2-E] [Cited by in Crossref: 76] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
318 Hunziker IP, Zurbriggen R, Glueck R, Engler OB, Reichen J, Dai WJ, Pichler WJ, Cerny A. Perspectives: towards a peptide-based vaccine against hepatitis C virus. Molecular Immunology 2001;38:475-84. [DOI: 10.1016/s0161-5890(01)00083-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
319 Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 1999;58:139-44. [PMID: 10335861 DOI: 10.1002/(sici)1096-9071(199906)58:2<139::aid-jmv7>3.0.co;2-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
320 Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gitnick G. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis 2000;35:122-9. [PMID: 10620553 DOI: 10.1016/S0272-6386(00)70310-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
321 Av Coates J, Smith PW. Review: Anti-infectives Developments in viral hepatitis during 1994. Expert Opinion on Therapeutic Patents 2008;5:747-56. [DOI: 10.1517/13543776.5.8.747] [Reference Citation Analysis]
322 Colombo M. Hepatitis C virus and hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 1999;13:519-28. [DOI: 10.1053/bega.1999.0045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
323 Ura K, Furusyo N, Ogawa E, Hayashi T, Mukae H, Shimizu M, Toyoda K, Murata M, Hayashi J. Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C. Aliment Pharmacol Ther 2016;43:114-24. [PMID: 26503582 DOI: 10.1111/apt.13431] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
324 Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Stanzione M, Filippini P, Felaco FM, Piccinino F. Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment. J Med Virol. 2001;65:681-687. [PMID: 11745931 DOI: 10.1002/jmv.2090] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
325 Lu L, Li C, Fu Y, Gao F, Pybus OG, Abe K, Okamoto H, Hagedorn CH, Murphy D. Complete genomes of hepatitis C virus (HCV) subtypes 6c, 6l, 6o, 6p and 6q: completion of a full panel of genomes for HCV genotype 6. J Gen Virol 2007;88:1519-25. [PMID: 17412981 DOI: 10.1099/vir.0.82820-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
326 Belli LS, Zavaglia C, Alberti AB, Poli F, Rondinara G, Silini E, Taioli E, de Carlis L, Scalamogna M, Forti D, Pinzello G, Idèo G. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation: Influence of Immunogenetic Background on the Outcome of Recurrent Hepatitis C After Liver Transplantation. Hepatology 2000;31:1345-50. [DOI: 10.1053/jhep.2000.7879] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
327 Mizoguchi N, Mizokami M, Orito E, Shibata H, Shibata H. Serologically defined genotypes of hepatitis C virus among Japanese patients with chronic hepatitis C. Journal of Virological Methods 1996;58:71-9. [DOI: 10.1016/0166-0934(95)01989-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
328 Bortolotti F. Chronic viral hepatitis in childhood. Baillière's Clinical Gastroenterology 1996;10:185-206. [DOI: 10.1016/s0950-3528(96)90002-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
329 Sagnelli E, Alessio L, Sagnelli C, Gualdieri L, Pisaturo M, Minichini C, Di Caprio G, Starace M, Onorato L, Scotto G, Macera M, Coppola N. Clinical Findings of HCV Chronic Infection in Undocumented Immigrants and Low-Income Refugees in Three Areas of Southern Italy. Ann Hepatol 2018;17:47-53. [PMID: 29311411 DOI: 10.5604/01.3001.0010.7534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
330 Nishizawa Y, Tanaka E, Orii K, Rokuhara A, Ichijo T, Yoshizawa K, Kiyosawa K. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon. J Gastroenterol Hepatol. 2000;15:1292-1297. [PMID: 11129224 DOI: 10.1046/j.1440-1746.2000.2342.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
331 Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Sone Y, Kinoshita M, Hadama T. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol 1997;26:6-13. [PMID: 9148023 DOI: 10.1016/s0168-8278(97)80002-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
332 Toyoda H, Kumada T, Takaguchi K, Shimada N, Tanaka J. Changes in hepatitis C virus genotype distribution in Japan. Epidemiol Infect. 2014;142:2624-2628. [PMID: 24598252 DOI: 10.1017/s0950268814000478] [Cited by in Crossref: 42] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
333 Colombo M. Hepatocellular carcinoma in patients with HCV. Best Practice & Research Clinical Gastroenterology 2000;14:327-39. [DOI: 10.1053/bega.1999.0079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
334 Cardin R, Saccoccio G, Masutti F, Bellentani S, Farinati F, Tiribelli C. DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol. 2001;34:587-592. [PMID: 11394660 DOI: 10.1016/s0168-8278(00)00098-2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
335 Kenny-walsh E. THE NATURAL HISTORY OF HEPATITIS C VIRUS INFECTION. Clinics in Liver Disease 2001;5:969-77. [DOI: 10.1016/s1089-3261(05)70204-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
336 Djordjević V, Stojanović K, Stojanović M, Stefanović V. Prevention of Nosocomial Transmission of Hepatitis C Infection in a Hemodialysis Unit. A Prospective Study. Int J Artif Organs 2000;23:181-8. [DOI: 10.1177/039139880002300307] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
337 Ogawa E, Furusyo N, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Nakamuta M, Satoh T, Azuma K, Kawano A. Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection. Antiviral Res. 2014;104:102-109. [PMID: 24462955 DOI: 10.1016/j.antiviral.2014.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
338 Ozdemir FN, Akcay A, Sezer S, Boyacioglu S, Ozdemir BH, Arat Z, Haberal M. A Six‐Year Follow‐Up After Interferon‐Alpha Monotherapy for Chronic Hepatitis C Infection in Hemodialysis Patients. Renal Failure 2009;26:583-8. [DOI: 10.1081/jdi-200031725] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
339 Malaguarnera M, Pistone G, Neri S, Romano M, Brogna A, Musumeci S. Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment: . BioDrugs 2004;18:407-13. [DOI: 10.2165/00063030-200418060-00006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
340 Shaker OG, Eskander EF, Yahya SM, Mohamed MS, Abd-Rabou AA. Genetic variation in BCL-2 and response to interferon in hepatitis C virus type 4 patients. Clin Chim Acta 2011;412:593-8. [PMID: 21159314 DOI: 10.1016/j.cca.2010.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
341 Nomura H, Kimura Y, Tada H, Hisano C, Morita C, Okamoto O, Shiraishi G, Kashiwagi S. Predictive Factors of a Response to Interferon Therapy in Chronic Hepatitis C: . Journal of Clinical Gastroenterology 1996;23:185-90. [DOI: 10.1097/00004836-199610000-00006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
342 Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and “silent” HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol. 2001;64:350-355. [PMID: 11424125 DOI: 10.1002/jmv.1057] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 4.0] [Reference Citation Analysis]
343 Okanoue T, Makiyama A, Nakayama M, Sumida Y, Mitsuyoshi H, Nakajima T, Yasui K, Minami M, Itoh Y. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase. Journal of Hepatology 2005;43:599-605. [DOI: 10.1016/j.jhep.2005.04.008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
344 Talal AH, Ribeiro RM, Powers KA, Grace M, Cullen C, Hussain M, Markatou M, Perelson AS. Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders. Hepatology 2006;43:943-53. [PMID: 16761329 DOI: 10.1002/hep.21136] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
345 Ampurdanés S, Olmedo E, Maluenda MD, Forns X, López-labrador FX, Costa J, Sánchez-tapias JM, Jimenez de Anta MT, Rodés J. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. Journal of Hepatology 1996;25:827-32. [DOI: 10.1016/s0168-8278(96)80285-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
346 Holland J, Bastian I, Ratcliff RM, Beers MY, Hahesy P, Harley H, Shaw DR, Higgins GD. Hepatitis C genotyping by direct sequencing of the product from the Roche AMPLICOR test: methodology and application to a South Australian population. Pathology. 1998;30:192-195. [PMID: 9643505 DOI: 10.1080/00313029800169226] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
347 Thiers V, Jaffredo F, Tuveri R, Chodan N, Bréchot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Methods 1997;65:9-17. [PMID: 9128857 DOI: 10.1016/s0166-0934(96)02162-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
348 Moriyama M, Matsumura H, Aoki H, Shimizu T, Yamagami H, Shioda A, Kaneko M, Goto I, Tanaka N, Arakawa Y. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy. Liver Int. 2005;25:85-90. [PMID: 15698403 DOI: 10.1111/j.1478-3231.2005.01028.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
349 Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Akahoshi T, Maehara Y, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group. Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis. J Gastroenterol Hepatol 2014;29:1728-35. [PMID: 24731162 DOI: 10.1111/jgh.12619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
350 Blatt LM, Tong MJ, McHutchison JG, Russell J, Schmid P, Conrad A. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers. J Interferon Cytokine Res. 1998;18:75-80. [PMID: 9506457 DOI: 10.1089/jir.1998.18.75] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
351 Chamberlain RW, Adams NJ, Taylor LA, Simmonds P, Elliott RM. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun. 1997;236:44-49. [PMID: 9223423 DOI: 10.1006/bbrc.1997.6902] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 2.7] [Reference Citation Analysis]
352 Haydon G, Jarvis L, Simmonds P, Hayes P. Association between chronic hepatitis C infection and hepatocellular carcinoma. The Lancet 1995;345:928-9. [DOI: 10.1016/s0140-6736(95)90045-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
353 Piperno A, Sampietro M, D'Alba R, Roffi L, Fargion S, Parma S, Nicoli C, Corbetta N, Pozzi M, Arosio V. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver. 1996;16:248-254. [PMID: 8877995 DOI: 10.1111/j.1600-0676.1996.tb00737.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 2.6] [Reference Citation Analysis]
354 Dickson RC, Mizokami M, Orito E, Qian K, Lau JYN. QUANTIFICATION OF SERUM HCV CORE ANTIGEN BY A FLUORESCENT ENZYME IMMUNOASSAY IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C-CLINICAL AND VIROLOGIC IMPLICATIONS1: . Transplantation 1999;68:1512-6. [DOI: 10.1097/00007890-199911270-00014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
355 Petruzziello A, Marigliano S, Loquercio G, Coppola N, Piccirillo M, Leongito M, Azzaro R, Izzo F, Botti G. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study. Infect Agents Cancer 2017;12. [DOI: 10.1186/s13027-017-0162-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
356 Lau JY, Mizokami M, Davis GL, Kolberg JA, Urdea MS, Orito E, Polito A, Dinello R, Quan S. Relationship between the presence of circulating anti-GOR and hepatitis C viremia/genotype. Journal of Hepatology 1995;22:707. [DOI: 10.1016/0168-8278(95)80228-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
357 Hansurabhanon T, Jiraphongsa C, Tunsakun P, Sukbunsung R, Bunyamanee B, Kuirat P, Meedsen S, Waedeng W, Theamboonlers A, Poovorawan Y. Infection with hepatitis C virus among intravenous-drug users: prevalence, genotypes and risk-factor-associated behaviour patterns in Thailand. Annals of Tropical Medicine & Parasitology 2013;96:615-25. [DOI: 10.1179/000349802125001465] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
358 Kimura Y, Hayashida K, Ishibashi H, Niho Y, Yanagi Y. Antibody-free virion titer greatly differs between hepatitis C virus genotypes. J Med Virol 2000;61:37-43. [DOI: 10.1002/(sici)1096-9071(200005)61:1<37::aid-jmv6>3.0.co;2-e] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
359 Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997;35:201-7. [DOI: 10.1128/jcm.35.1.201-207.1997] [Cited by in Crossref: 327] [Cited by in F6Publishing: 122] [Article Influence: 13.1] [Reference Citation Analysis]
360 Zusinaite E, Metsküla K, Salupere R. Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia. World J Gastroenterol 2005; 11(4): 488-491 [PMID: 15641131 DOI: 10.3748/wjg.v11.i4.488] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
361 Herrero Martínez E. Hepatitis B and hepatitis C co-infection in patients with HIV. Rev Med Virol 2001;11:253-70. [PMID: 11479931 DOI: 10.1002/rmv.323] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
362 Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Oshita M, Katayama K, Kasahara A, Fusamoto H, Kamada T. Serial density analysis of hepatitis C virus particle populations in chronic hepatitis C patients treated with interferon-alpha. J Med Virol 1995;46:230-7. [PMID: 7561795 DOI: 10.1002/jmv.1890460311] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
363 Oubiña JR, Quarleri JF, Rudzinski M, Parks C, Badía I, Cappa SMG. Genomic characterization of hepatitis C virus isolates from Argentina. J Med Virol 1995;47:97-104. [DOI: 10.1002/jmv.1890470118] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
364 Yuki N, Hayashi N, Mita E, Hagiwara H, Oshita M, Ohkawa K, Katayama K, Kasahara A, Fusamoto H, Kamada T. Clinical characteristics and antibody profiles of chronic hepatitis C patients: Relation to hepatitis C virus genotypes. J Med Virol 1995;45:162-7. [DOI: 10.1002/jmv.1890450209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
365 Liddle C. Hepatitis C. Anaesth Intensive Care 1996;24:180-3. [DOI: 10.1177/0310057x9602400209] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
366 Pawlotsky JM, Roudot-thoraval F, Pellet C, Aumont P, Darthuy F, Remire J, Duval J, Dhumeaux D. Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns. J Clin Microbiol 1995;33:1357-9. [DOI: 10.1128/jcm.33.5.1357-1359.1995] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
367 Mitchell PS, Sloan LM, Majewski DW, Rys PN, Heimgartner PJ, Rosenblatt JE, Cockerill FR 3rd, Smith TF, Patel R. Comparison of line probe assay and DNA sequencing of 5' untranslated region for genotyping hepatitis C virus: description of novel line probe patterns. Diagn Microbiol Infect Dis. 2002;42:175-179. [PMID: 11929688 DOI: 10.1016/s0732-8893(01)00349-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
368 Timm J, Roggendorf M. Sequence diversity of hepatitis C virus: Implications for immune control and therapy. World J Gastroenterol 2007; 13(36): 4808-4817 [PMID: 17828811 DOI: 10.3748/wjg.v13.i36.4808] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
369 Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A. Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy. J Hepatol. 2013;59:667-674. [PMID: 23707372 DOI: 10.1016/j.jhep.2013.05.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
370 Koshy A, Madda JP, Marcellin P, Martinot M. Treatment of hepatitis C virus genotype 4-related cirrhosis: ribavirin and interferon combination compared with interferon alone. J Clin Gastroenterol 2002;35:82-5. [PMID: 12080232 DOI: 10.1097/00004836-200207000-00017] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
371 Mancini C, Zerbini M, Azzi A, Piunno M. Multicentre Italian Study Group (MISG) for the standardisation of hepatitis C virus (HCV) PCR. Journal of Clinical Virology 2003;27:83-9. [DOI: 10.1016/s1386-6532(02)00132-4] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
372 Nagayama K, Kurosaki M, Enomoto N, Maekawa SY, Miyasaka Y, Tazawa J, Izumi N, Marumo F, Sato C. Time-related changes in full-length hepatitis C virus sequences and hepatitis activity. Virology 1999;263:244-53. [PMID: 10544098 DOI: 10.1006/viro.1999.9924] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
373 dos Santos Riccardi C, Kranz C, Kowalik J, Yamanaka H, Mizaikoff B, Josowicz M. Label-free DNA detection of hepatitis C virus based on modified conducting polypyrrole films at microelectrodes and atomic force microscopy tip-integrated electrodes. Anal Chem. 2008;80:237-245. [PMID: 18034460 DOI: 10.1021/ac701613t] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 3.8] [Reference Citation Analysis]
374 Nomura H, Sou S, Tanimoto H, Nagahama T, Kimura Y, Hayashi J, Ishibashi H, Kashiwagi S. Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial. Hepatology. 2004;39:1213-1219. [PMID: 15122749 DOI: 10.1002/hep.20196] [Cited by in Crossref: 121] [Cited by in F6Publishing: 106] [Article Influence: 6.7] [Reference Citation Analysis]
375 Mizokami M, Lau JY, Suzuki K, Nakano T, Gojobori T. Differential sensitivity of hepatitis C virus quasispecies to interferon-α therapy. Journal of Hepatology 1994;21:884-6. [DOI: 10.1016/s0168-8278(94)80254-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
376 Navas S, Martín J, Quiroga JA, Castillo I, Carreño V. Genetic Diversity and Tissue Compartmentalization of the Hepatitis C Virus Genome in Blood Mononuclear Cells, Liver, and Serum from Chronic Hepatitis C Patients. J Virol 1998;72:1640-6. [DOI: 10.1128/jvi.72.2.1640-1646.1998] [Cited by in Crossref: 102] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
377 Marcus E, Tur-kaspa R. Viral Hepatitis in Older Adults. Journal of the American Geriatrics Society 1997;45:755-63. [DOI: 10.1111/j.1532-5415.1997.tb01484.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
378 Brechot C. Virus de l'hépatite C : structure et variabilité génétique. Médecine et Maladies Infectieuses 1995;25:1056-66. [DOI: 10.1016/s0399-077x(05)80895-9] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
379 Cooreman MP, Schoondermark-Van de Ven EM. Hepatitis C virus: biological and clinical consequences of genetic heterogeneity. Scand J Gastroenterol Suppl 1996;218:106-15. [PMID: 8865460 DOI: 10.3109/00365529609094740] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
380 Tapper EB, Afdhal NH. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3. J Viral Hepat. 2013;20:669-677. [PMID: 24010641 DOI: 10.1111/jvh.12168] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
381 Ohno T, Mizokami M, Yamauchi M, Ohba K, Orito E, Wu R, Mizuno M, Sugihara K, Wakita T, Kakumu S. Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus. J Gastroenterol 1995;30:209-14. [DOI: 10.1007/bf02348667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
382 Jesudian AB, de Jong YP, Jacobson IM. Emerging therapeutic targets for hepatitis C virus infection. Clin Gastroenterol Hepatol 2013;11:612-9.e1. [PMID: 23583900 DOI: 10.1016/j.cgh.2013.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
383 Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy. J Med Virol 1995;46:162-8. [DOI: 10.1002/jmv.1890460215] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
384 Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001;38:919-34. [PMID: 11684543 DOI: 10.1053/ajkd.2001.28576] [Cited by in Crossref: 89] [Cited by in F6Publishing: 69] [Article Influence: 4.2] [Reference Citation Analysis]
385 Kendrick EA, McVicar JP, Kowdley KV, Bronner MP, Emond MJ, Alpers CE, Gretch DR, Carithers RL, Perkins JD, Davis CL. Renal disease in hepatitis C-positive liver transplant recipients. Transplantation. 1997;63:1287-1293. [PMID: 9158023 DOI: 10.1097/00007890-199705150-00016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
386 Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107-115. [PMID: 21091831 DOI: 10.1111/j.1469-0691.2010.03432.x] [Cited by in Crossref: 864] [Cited by in F6Publishing: 816] [Article Influence: 78.5] [Reference Citation Analysis]
387 Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, Goto H, Kumada T, Takamatsu J. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol. 2004;73:195-199. [PMID: 15122792 DOI: 10.1002/jmv.20075] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
388 Serfaty L, Aumaître H, Chazouillères O, Bonnand A, Rosmorduc O, Poupon RE, Poupon R. Determinants of outcome of compensated hepatitis C virus-related cirrhosis: Determinants of Outcome of Compensated Hepatitis C Virus-Related Cirrhosis. Hepatology 1998;27:1435-40. [DOI: 10.1002/hep.510270535] [Cited by in Crossref: 288] [Cited by in F6Publishing: 268] [Article Influence: 15.2] [Reference Citation Analysis]
389 Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology. 1998;28:823-830. [PMID: 9731579 DOI: 10.1002/hep.510280333] [Cited by in Crossref: 452] [Cited by in F6Publishing: 413] [Article Influence: 18.8] [Reference Citation Analysis]
390 Watanabe K, Yoshioka K, Yano M, Ishigami M, Ukai K, Ito H, Miyata F, Mizutani T, Goto H. Mutations in the nonstructural region 5B of hepatitis C virus genotype 1b: their relation to viral load, response to interferon, and the nonstructural region 5A. J Med Virol 2005;75:504-12. [PMID: 15714488 DOI: 10.1002/jmv.20301] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
391 Qin W, Luo H, Nomura T, Hayashi N, Yamashita T, Murakami S. Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase. J Biol Chem 2002;277:2132-7. [PMID: 11673460 DOI: 10.1074/jbc.M106880200] [Cited by in Crossref: 78] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
392 Benvegnù L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis: Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997;25:211-5. [DOI: 10.1002/hep.510250138] [Cited by in Crossref: 115] [Cited by in F6Publishing: 91] [Article Influence: 6.1] [Reference Citation Analysis]
393 Mihály I, Telegdy L, Ibrányi E, Lukács A, Rókusz L, Bánkuti E E, Dóczy J. Prevalence, genotype distribution and outcome of hepatitis C infections among the employees of the Hungarian Central Hospital for infectious diseases. J Hosp Infect 2001;49:239-44. [PMID: 11740870 DOI: 10.1053/jhin.2001.1087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
394 Germer JJ, Zein NN. Advances in the molecular diagnosis of hepatitis C and their clinical implications. Mayo Clin Proc 2001;76:911-20. [PMID: 11560302 DOI: 10.4065/76.9.911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
395 Feucht HH, Zöllner B, Schröter M, Hoyer A, Sterneck M, Polywka S. Distribution of genotypes and response to alpha-interferon in patients with hepatitis C virus infection in Germany. Eur J Clin Microbiol Infect Dis 1996;15:128-32. [DOI: 10.1007/bf01591485] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
396 Ramadori G, Meier V. Hepatitis C virus infection: 10 years after the discovery of the virus. Eur J Gastroenterol Hepatol 2001;13:465-71. [PMID: 11396522 DOI: 10.1097/00042737-200105000-00001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
397 Tassopoulos NC. Patterns of progression: Unpredictability and risk of decompensated cirrhosis. Digest Dis Sci 1996;41:41S-8S. [DOI: 10.1007/bf02087875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
398 Fabris P, Infantolino D, Biasin MR, Marchelle G, Venza E, Wiel Marin VT, Benedetti P, Tositti G, Manfrin V, de Lalla F. High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no Evidence of HCV transmission among sexual partners. Infection 1999;27:86-91. [DOI: 10.1007/bf02560503] [Cited by in Crossref: 28] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
399 Stribling R, Sussman N, Vierling JM. Treatment of hepatitis C infection. Gastroenterol Clin North Am. 2006;35:463-486. [PMID: 16880075 DOI: 10.1016/j.gtc.2006.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
400 Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 2001;20:41-7. [PMID: 11163582 DOI: 10.1016/s1386-6532(00)00154-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
401 Siler CA, Mcgettigan JP, Dietzschold B, Herrine SK, Dubuisson J, Pomerantz RJ, Schnell MJ. Live and Killed Rhabdovirus-Based Vectors as Potential Hepatitis C Vaccines. Virology 2002;292:24-34. [DOI: 10.1006/viro.2001.1212] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
402 Bonkovsky HL, Mehta S. Hepatitis C: A review and update. Disease-a-Month 2001;47:610-47. [DOI: 10.1016/s0011-5029(01)90007-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
403 Watanabe A, Shimokawa T, Moriyama M, Komine F, Amaki S, Arakawa Y, Ra C. Genetic variants of the IgA Fc receptor (FcαR, CD89) promoter in chronic hepatitis C patients. Immunogenetics 2006;58:937-46. [DOI: 10.1007/s00251-006-0159-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
404 Mizokami M, Orito E, Gibo Y, Suzuki K, Ohba K, Ohno T, Lau JY. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C. Liver 1996;16:23-7. [PMID: 8868074 DOI: 10.1111/j.1600-0676.1996.tb00699.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
405 Suzuki K, Shinzawa H, Kuboki M, Ishibashi M, Yoshii E, Saito T, Takahashi T. Secondary structure of the hepatitis C virus 5' untranslated region and efficacy of interferon therapy for chronic hepatitis C. Liver 1998;18:331-6. [PMID: 9831362 DOI: 10.1111/j.1600-0676.1998.tb00814.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
406 Basaras M, Lombera N, de las Heras B, López C, Arrese E, Cisterna R. Distribution of HCV genotypes in patients infected by different sources. Research in Virology 1997;148:367-73. [DOI: 10.1016/s0923-2516(97)89133-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
407 Li C, Fu Y, Lu L, Ji W, Yu J, Hagedorn CH, Zhang L. Complete genomic sequences for hepatitis C virus subtypes 6e and 6g isolated from Chinese patients with injection drug use and HIV-1 co-infection. J Med Virol 2006;78:1061-9. [PMID: 16789024 DOI: 10.1002/jmv.20663] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
408 Kessler HH, Santner BI, Umlauft F, Kronawetter M, Stünzner D, Pierer K, Stelzl E, Grünewald K, Marth E. Quantitation and genotyping of hepatitis C virus RNA in sera of hemodialysis and AIDS patients. Clinical and Diagnostic Virology 1996;5:73-8. [DOI: 10.1016/0928-0197(95)00154-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
409 Nolte FS. Laboratory diagnosis of hepatitis C. Immunol Invest 1997;26:199-207. [PMID: 9037624 DOI: 10.3109/08820139709048927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
410 Yasui K, Harano Y, Mitsuyoshi H, Tsuji K, Endo M, Nakajima T, Minami M, Itoh Y, Zen Y, Nakanuma Y. Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus. J Gastroenterol. 2010;45:95-104. [PMID: 19789836 DOI: 10.1007/s00535-009-0133-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
411 Cochrane A, Simmonds P. Molecular Epidemiology of Hepatitis C Virus. In: Leitner T, editor. The Molecular Epidemiology of Human Viruses. Boston: Springer US; 2002. pp. 197-216. [DOI: 10.1007/978-1-4615-1157-1_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
412 Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Bréchot C. Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney International 1995;47:1412-8. [DOI: 10.1038/ki.1995.198] [Cited by in Crossref: 89] [Cited by in F6Publishing: 68] [Article Influence: 3.3] [Reference Citation Analysis]
413 Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB, Wiesner R, Persing D. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation. 1997;63:1419-1423. [PMID: 9175804 DOI: 10.1097/00007890-199705270-00009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 3.4] [Reference Citation Analysis]
414 Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, Takamatsu J, Imoto M, Hayakawa T. A long-term follow-up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders. European Journal of Haematology 1996;57:165-70. [DOI: 10.1111/j.1600-0609.1996.tb01355.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
415 Aoki M. [Maintenance of the posture and synergic reflex]. Nihon Rinsho. 1975;33:2978-2984. [PMID: 1239534 DOI: 10.1053/jhep.2002.36509] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 2.1] [Reference Citation Analysis]
416 Kao JH, Chen PJ, Wang JT, Yang PM, Lai MY, Wang TH, Chen DS. Superinfection by homotypic virus in hepatitis C virus carriers: Studies on patients with post-transfusion hepatitis. J Med Virol 1996;50:303-8. [DOI: 10.1002/(sici)1096-9071(199612)50:4<303::aid-jmv4>3.0.co;2-c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
417 Himoto T, Yoneyama H, Kurokohchi K, Inukai M, Masugata H, Goda F, Haba R, Watababe S, Kubota S, Senda S, Masaki T. Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease. Nutr Res 2011;31:829-35. [PMID: 22118753 DOI: 10.1016/j.nutres.2011.09.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
418 Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre. J Hepatol 1996;25:821-6. [PMID: 9007708 DOI: 10.1016/s0168-8278(96)80284-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
419 Doutre MS, Beylot C, Beylot-Barry M, Couzigou P, Beylot J. [Skin manifestations related to hepatitis C viruses]. Rev Med Interne 1995;16:666-72. [PMID: 7481154 DOI: 10.1016/0248-8663(96)80769-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
420 Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A. Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study. Aliment Pharmacol Ther. 2013;38:1076-1085. [PMID: 24099469 DOI: 10.1111/apt.12494] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
421 Brass V, Blum HE, Moradpour D. Recent developments in target identification against hepatitis C virus. Expert Opinion on Therapeutic Targets 2005;8:295-307. [DOI: 10.1517/14728222.8.4.295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
422 Takamatsu J, Toyoda H, Fukuda Y, Nakano I, Yokozaki S, Hayashi K, Saito H. Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiply coinfected HIV-positive patients with haemophilia. Haemophilia 2001;7:575-81. [PMID: 11851756 DOI: 10.1046/j.1365-2516.2001.00567.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
423 Zein NN, Persing DH, Czaja AJ. Viral genotypes as determinants of autoimmune expression in chronic hepatitis C. Mayo Clin Proc. 1999;74:454-460. [PMID: 10319074 DOI: 10.4065/74.5.454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
424 Pan QW, Henry SD, Scholte BJ, Tilanus HW, Janssen HL, Laan LJVD. New therapeutic opportunities for Hepatitis C based on small RNA. World J Gastroenterol 2007; 13(33): 4431-4436 [PMID: 17724797 DOI: 10.3748/wjg.v13.i33.4431] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
425 Castilho MC, Martins AN, Horbach IS, Perez Rde M, Figueiredo FA, Pinto Pde T, Nabuco LC, Lima DB, Tanuri A, Porto LC, Ferreira Júnior Oda C. Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients. Mem Inst Oswaldo Cruz 2011;106:968-75. [PMID: 22241118 DOI: 10.1590/s0074-02762011000800011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
426 Sugawara Y, Makuuchi M, Matsui Y, Kishi Y, Akamatsu N, Kaneko J, Kokudo N. Preemptive therapy for hepatitis C virus after living-donor liver transplantation. Transplantation. 2004;78:1308-1311. [PMID: 15548968 DOI: 10.1097/01.tp.0000142677.12473.e5] [Cited by in Crossref: 100] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
427 Schreier E, Roggendorf M, Driesel G, Höhne M, Viazov S. Genotypes of hepatitis C virus isolates from different parts of the world. Arch Virol Suppl 1996;11:185-93. [PMID: 8800799 DOI: 10.1007/978-3-7091-7482-1_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.0] [Reference Citation Analysis]
428 Gervais A, Martinot M, Boyer N, Auperin A, Le Breton W, Degott C, Valla D, Marcellin P. Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment. J Hepatol 2001;35:399-405. [PMID: 11592602 DOI: 10.1016/s0168-8278(01)00138-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
429 Anthony DD, Post AB, Valdez H, Peterson DL, Murphy M, Heeger PS. ELISPOT Analysis of Hepatitis C Virus Protein-Specific IFN-γ-Producing Peripheral Blood Lymphocytes in Infected Humans with and without Cirrhosis. Clinical Immunology 2001;99:232-40. [DOI: 10.1006/clim.2001.5018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
430 Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, Tatsumi T, Ito A, Mochizuki K. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology. 1998;27:240-244. [PMID: 9425943 DOI: 10.1002/hep.510270136] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 4.9] [Reference Citation Analysis]
431 Dvory-Sobol H, Han B, Lu J, Yu M, Beran RK, Cheng G, Martin R, Svarovskaia E, Mo H. In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6. J Viral Hepat 2019;26:991-1001. [PMID: 31009123 DOI: 10.1111/jvh.13116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
432 Basaras M, Arrese E, Cabrera F, Cisterna CAR. Detection of HGV in serum and peripheral blood mononuclear cells of maintenance haemodialysis patients. Journal of Hospital Infection 1999;42:155-9. [DOI: 10.1053/jhin.1998.0546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
433 Halfon P, Khiri H, Feryn JM, Sayada C, Chanas M, Ouzan D. Prospective virological follow‐up of hepatitis C infection in a haemodialysis unit. Journal of Viral Hepatitis 2002;5:115-21. [DOI: 10.1046/j.1365-2893.1998.00089.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
434 McGarvey MJ, Iqbal M, Nastos T, Karayiannis P. Restricted quasispecies variation following infection with the GB virus B. Virus Res 2008;135:181-6. [PMID: 18455258 DOI: 10.1016/j.virusres.2008.03.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
435 Fabrizi F, Martin P, Quan S, Dixit V, Brezina M, Conrad A, Polito A, Gitnick G. Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients. American Journal of Kidney Diseases 2000;35:832-8. [DOI: 10.1016/s0272-6386(00)70252-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
436 Malet I, Belnard M, Agut H, Cahour A. From RNA to quasispecies: a DNA polymerase with proofreading activity is highly recommended for accurate assessment of viral diversity. Journal of Virological Methods 2003;109:161-70. [DOI: 10.1016/s0166-0934(03)00067-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
437 Park SH, Bang CS, Kim DJ. Biomarkers in HCV Infection. Adv Clin Chem 2015;70:131-96. [PMID: 26231487 DOI: 10.1016/bs.acc.2015.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
438 Livache T, Fouque B, Roget A, Marchand J, Bidan G, Téoule R, Mathis G. Polypyrrole DNA chip on a silicon device: example of hepatitis C virus genotyping. Anal Biochem. 1998;255:188-194. [PMID: 9451503 DOI: 10.1006/abio.1997.2462] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 5.0] [Reference Citation Analysis]
439 Fukuda R, Ishimura N, Kushiyama Y, Moriyama N, Ishihara S, Nagasawa S, Miyake T, Niigaki M, Satoh S, Sakai S, Akagi S, Watanabe M, Fukumoto S. Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. Journal of Hepatology 1997;26:455-61. [DOI: 10.1016/s0168-8278(97)80407-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
440 Weck K. Molecular methods of hepatitis C genotyping. Expert Rev Mol Diagn. 2005;5:507-520. [PMID: 16013969 DOI: 10.1586/14737159.5.4.507] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
441 Heathcote EJ, Keeffe EB, Lee SS, Feinman SV, Tong MJ, Reddy KR, Albert DG Jr, Witt K, Blatt LM. Re-treatment of chronic hepatitis C with consensus interferon. Hepatology. 1998;27:1136-1143. [PMID: 9537455 DOI: 10.1002/hep.510270431] [Cited by in Crossref: 117] [Cited by in F6Publishing: 103] [Article Influence: 4.9] [Reference Citation Analysis]
442 Waqar M, Khan AU, Rehman HU, Idrees M, Wasim M, Ali A, Niaz Z, Ismail Z, Rehman MU, Tariq M. Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan). Eur J Gastroenterol Hepatol. 2014;26:59-64. [PMID: 23743560 DOI: 10.1097/meg.0b013e328362dc3f] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
443 Isobe K, Imoto M, Fukuda Y, Koyama Y, Nakano I, Hayakawa T, Takamatsu J. Hepatitis C virus infection and genotypes in Japanese hemophiliacs. Liver 1995;15:131-4. [PMID: 7545774 DOI: 10.1111/j.1600-0676.1995.tb00659.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
444 Ohkawa K, Hayashi N, Yuki N, Kasahara A, Oshita M, Mochizuki K, Katayama K, Fusamoto H, Kato M, Masuzawa M, Yoshihara H, Mukuda T, Kamada T. Disease stage of chronic hepatitis C assessed by both peritoneoscopic and histologic findings and its relationship with response to interferon therapy. Gastrointestinal Endoscopy 1997;45:168-75. [DOI: 10.1016/s0016-5107(97)70242-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
445 Sacco R, Randone A, Flichman D, Oliveri F, Colombatto P, Scaraggi FA, Bonino F, Schiraldi O, Brunetto MR. The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. Clinical and Diagnostic Virology 1997;8:189-94. [DOI: 10.1016/s0928-0197(97)00019-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
446 Marcellin P, Pouteau M, Martinot-peignoux M, Degos F, Duchatelle V, Boyer N, Lemonnier C, Degott C, Erlinger S, Benhamou JP. Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C. Gastroenterology 1995;109:156-65. [DOI: 10.1016/0016-5085(95)90281-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 2.3] [Reference Citation Analysis]
447 Gonzalez SA, Liu R, Edlin BR, Jacobson IM, Talal AH. HIV/Hepatitis C Virus-Coinfected Patients With Normal Alanine Aminotransferase Levels. JAIDS Journal of Acquired Immune Deficiency Syndromes 2006;41:582-9. [DOI: 10.1097/01.qai.0000214806.90841.c8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
448 Mizokami M, Gojobori T, Ohba K, Ikeo K, Ge X, Ohno T, Orito E, Lau JY. Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes. Journal of Hepatology 1996;24:622-4. [DOI: 10.1016/s0168-8278(96)80149-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
449 Yabaji PM, Shankarkumar A, Shukla A, Bhatia S. Hepatitis C virus infection in a tertiary care hospital in Mumbai, India: Identification of a mixed and novel genotype. Indian J Med Microbiol 2018;36:352-6. [PMID: 30429386 DOI: 10.4103/ijmm.IJMM_18_221] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
450 Himoto T, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Haba R, Masugata H, Masaki T. Exacerbation of insulin resistance and hepatic steatosis deriving from zinc deficiency in patients with HCV-related chronic liver disease. Biol Trace Elem Res. 2015;163:81-88. [PMID: 25413880 DOI: 10.1007/s12011-014-0177-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
451 Craxì A, Di Marco V, Lo Iacono O, Almasio P, Bruno R, Cammà C, Volpes R, Pagliaro L. Transfusion-associated chronic hepatitis C: alpha-n1 interferon for 6 vs. 12 months. J Hepatol 1996;24:539-46. [PMID: 8773908 DOI: 10.1016/s0168-8278(96)80138-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
452 Simmonds P. Viral heterogeneity of the hepatitis C virus. J Hepatol. 1999;31 Suppl 1:54-60. [PMID: 10622561 DOI: 10.1016/s0168-8278(99)80375-4] [Cited by in Crossref: 161] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
453 Ndjomou J, Kupfer B, Kochan B, Zekeng L, Kaptue L, Matz B. Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon. J Med Virol. 2002;66:179-186. [PMID: 11782926 DOI: 10.1002/jmv.2128] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
454 Zein NN. Experimental and emerging therapies for chronic hepatitis C virus infection. Expert Opinion on Investigational Drugs 2005;10:1457-69. [DOI: 10.1517/13543784.10.8.1457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
455 Bonkovsky HL, Mehta S. Hepatitis C: A review and update. Journal of the American Academy of Dermatology 2001;44:159-82. [DOI: 10.1067/mjd.2001.109311] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
456 Soni P, Dusheiko G, Harrison T, Dhillon A. Genetic diversity of hepatitis C virus: implications for pathogenesis, treatment, and prevention. The Lancet 1995;345:562-6. [DOI: 10.1016/s0140-6736(95)90470-0] [Cited by in Crossref: 13] [Article Influence: 0.5] [Reference Citation Analysis]
457 Colloredo G, Roffi L, Brunetto MR, Leandro G, Brugnetti B, Bissoli F, Scalori A, Mancia G, Civardi E, Idéo G, Bonino F, Bellati G. Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy. J Viral Hepat 1999;6:373-80. [PMID: 10607253 DOI: 10.1046/j.1365-2893.1999.00184.x] [Reference Citation Analysis]
458 Campiotto S, Pinho J, Carrilho F, Da Silva L, Souto F, Spinelli V, Pereira L, Coelho H, Silva A, Fonseca J, Rosa H, Lacet C, Bernardini A. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 2005;38:41-9. [DOI: 10.1590/s0100-879x2005000100007] [Cited by in Crossref: 115] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
459 Frangeul L, Musset L, Cresta P, Cacoub P, Huraux J, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. Journal of Hepatology 1996;25:427-32. [DOI: 10.1016/s0168-8278(96)80200-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
460 Ko JS, Choe YH, Kim EJ, Lee EH, Jang J, Seo JK. Interferon-α Treatment of Chronic Hepatitis C in Children with Hemophilia: . Journal of Pediatric Gastroenterology and Nutrition 2001;32:41-4. [DOI: 10.1097/00005176-200101000-00013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
461 Fujita N, Kaito M, Ishida S, Nakagawa N, Ikoma J, Adachi Y, Watanabe S. Paraformaldehyde protects of hepatitis C virus particles during ultracentrifugation. J Med Virol 2001;63:108-16. [DOI: 10.1002/1096-9071(20000201)63:2<108::aid-jmv1004>3.0.co;2-6] [Cited by in Crossref: 12] [Article Influence: 0.6] [Reference Citation Analysis]
462 Roy K, Bagg J. Hepatitis C virus and oral disease: a critical review. Oral Dis 1999;5:270-7. [PMID: 10561713 DOI: 10.1111/j.1601-0825.1999.tb00089.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
463 Martinez‐sierra C, Arizcorreta A, Diaz F, Roldan R, Martin‐herrera L, Perez‐guzman E, Giron‐gonzalez JA. Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus. CLIN INFECT DIS 2003;36:491-8. [DOI: 10.1086/367643] [Cited by in Crossref: 178] [Cited by in F6Publishing: 169] [Article Influence: 9.4] [Reference Citation Analysis]
464 Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M. 8-Hydroxy-2’-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2008;23:1431-1436. [PMID: 18854000 DOI: 10.1111/j.1440-1746.2008.05502.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]